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Abstract 
 
Sheep blowfly strike imposes significant economic costs of $260 million annually from disruptions 
to farm management operations
1, 2
 associated with high labour cost of controlling flystrike,
3
 sheep 
morbidity and mortality, and loss of wool productivity.
4
 Mulesing, the surgical removal of skin 
from the breech which minimises soiling and reduces susceptibility to flystrike, is performed 
without anaesthetic and is therefore perceived as cruel and painful as reflected by physiological and 
behavioural alterations in affected lambs.
5, 6
 Intra-dermal sodium lauryl sulfate (SLS) was trialled in 
this study as a potential chemical alternative to mulesing. A sound mulesing alternative would 
ideally provide efficient wound healing and hairless scar formation which increases the bare area of 
the breech while causing minimal discomfort to the animal. 
 
In a sighting study, 3 Merino wethers were given intra-dermal injections of SLS at specific sites on 
the flank which were biopsied at different time points over 28 days. Assessments were made on 
gross and histological changes of wound healing as well as early behavioural indicators of pain. 
Based on the results of the sighting study, the following protocol refinements were made for the 
main study which used 6 Merino wethers, to:  
1) reduce biopsy frequency with concentration around specimens of histopathologic interest;  
2) expand lesion parameters and sharpen the grading process;  
3) improve SLS delivery using a pressurized needleless applicator; 
4) incorporate analysis of SLS’s mode of action at the ultrastructural level; 
5) improve the approach for pain assessment.  
 
Treated sheep showed minimal behavioural or postural indicators of pain or discomfort, their 
appetite was normal and there was a net gain in body weight, when compared with their untreated 
cohorts. Gross appearance of the treatment site consisted of initial swelling which subsided by day 
14 leaving a firm, slightly raised, crust.  At day 21, the treated area was depressed and covered by a 
scab (eschar) which partially sloughed off by day 28.   
 
Histological examination revealed necrosis of soft tissue structures (including hair bulbs, collagen, 
vessels and nerves) in the subcutis and deep dermis at 2 minutes after treatment, followed by 
subsequent additional ischaemic necrosis of the superficial dermis and epidermis with progressive 
inflammation, proliferation and remodelling of the wound. Fibroplasia and angiogenesis were 
accompanied with reepithelialisation starting at day 7, subjacent to areas of full dermal-epidermal 
necrosis which subsequently formed into eschars and partially sloughed off. Wound healing with 
3 
 
complete reepithelialisation took approximately 21 days. The reepithelialised scar tissue lacked 
adnexal units (hair follicles and their associated glands). 
  
Ultrastructural examination revealed necrosis manifesting as severely damaged vascular 
endothelium and follicular basal lamina, which resulted in loss of structural integrity and 
accumulation of extracellular fluid. Connective tissue ground substance in the extracellular matrix 
adjacent to the degenerated basal lamina was disorganized which inferred disruption of protein 
fibres embedded in the mixture of proteoglycan molecules and their glycosaminoglycan units, and 
supported the presence of interstitial oedema. Degeneration of remaining soft tissue structures was 
inferred from the observed widespread histopathologic necrosis.  
 
Histologic and ultrastructural findings confirmed the fundamental loss of structural integrity of 
cellular membranes of tissue components which is consistent with the mode of action of SLS which 
involves binding strongly to proteins of cellular membranes, resulting in protein unfolding and 
inactivation.
7, 8
 Consequently, intra-dermal SLS caused rapid local necrosis followed by eschar 
formation and scarring of treated skin. From its effects on the destruction of sensory nerves and 
adnexal units, intra-dermal SLS has been shown in this study to be potentially useful as a less 
painful chemical alternative to mulesing. The resulting scar formation would tighten skin and 
increase the bare area of the breech, thus minimising faecal and urine contamination which 
predisposes to flystrike. 
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Figure 1: Caudal aspect of sheep depicting the removal of skin (hatched) areas during mulesing (‘V’ 
mules) procedure; the tail is docked concurrently. 
 
Figure 2: Sheep skin showing a compound hair follicle (CHF) with a primary follicle (PF) and 
associated arrector pilli muscle (APM), sebaceous gland (SG) and apocrine gland (AG), and 
secondary follicles (SF). Haematoxylin and eosin stained section. Bar = 502µm. Magnification = 
400x. 
 
Figure 3: The sequence of events in normal wound healing which involves the overlapping stages of 
haemostasis, inflammation, proliferation and remodelling; adapted from Ginn et al, 2007.
138
 
 
Figure 4: Diagrammatic representation of 10 treatment sites each separated by a distance of 5 cm 
and composed of a 2 x 2, 1-cm
2
 grid area to receive 4 intra-dermal injections. Treatment sites were 
organized into 2 rows on each sides of the flank of the sheep involved in the sighting study. Skin 
biopsies were taken from the centre of individual treatment sites. 
 
Figure 5: Mean scores and standard deviations of gross skin appearance at different times after SLS 
treatment of 3 sheep in the sighting study. The mean scores and standard deviations of gross 
changes of the treatment sites were based on subjective scores of (0) normal, (1) mild swelling, <1.5 
cm diameter; (2) moderate swelling, <2.5 cm with redness, crusting or scab formation; or (3) severe 
swelling, >3.0 cm with blanching or redness. 
 
Figure 6: Histopathology at different time points following SLS treatment. Sheep skin; H & E 
stained sections. 
A. Deep hair bulbs were basophilic with irregular basement membrane (1) and collagenous 
necrosis characterised by hypereosinophilia with loss of cellular details (2) at 2 minutes. Bar = 
502 µm; magnification = 400x.   
B. A higher magnification showing necrosis of nerve bundle (1), vessel (2) and collagen (3) at 2 
minutes. Bar = 514 µm; magnification = 1000x 
C. Fibroplasia and angiogenesis in the deep dermis at day 7. Bar = 498µm; magnification = 200x. 
D. Dermal fibrosis lacking adnexal structures, with complete reepithelialisation (1) subjacent to 
the necrotic eschar (2) at day 28. Bar = 498µm; magnification = 200x. 
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Figure 7: Diagrammatic representation of how the delivery tubes of the nozzle head were evenly 
loaded against the skin surface to ensure uniform intra-dermal deposition of SLS; adapted from 
Welch, 2010.
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Figure 8: The nozzle head of the needleless applicator, SkinTraction® (measuring 50 mm in entire 
length and 22 mm in base diameter) consists of 4 delivery tubes, arranged in a grid and separated at 
a distance of 10 mm.   
 
Figure 9: Mean scores and standard deviations of gross skin appearance at different times after SLS 
treatment of 6 sheep in the main study. The mean scores and standard deviations of gross changes 
of the treatment sites were based on subjective scores of (0) normal, (1) mild swelling, <1.5 cm 
diameter; (2) moderate swelling, <2.5 cm with redness, crusting or scab formation; or (3) severe 
swelling, >3.0 cm with blanching or redness. 
 
Figure 10: Tissue hypereosinophilia with loss of cellular detail indicating coagulative necrosis; 
interstitial separation (1), lymphatic dilation (2) and distortion of deep hair bulbs (3) at 2 minutes 
after SLS treatment. Sheep skin; haematoxylin and eosin stained section. Bar = 502µm. 
Magnification = 400x. 
 
Figure 11: Acute inflammation of the subcutis and deep dermis developed 6 hours after treatment. 
The tissue architecture was altered by necrosis, moderate neutrophilic infiltration (1) and oedema 
characterised by interstitial separation (2) and lymphatic dilation (3). Sheep skin; haematoxylin and 
eosin stained section. Bar = 498µm. Magnification = 200x. 
 
Figure 12: At 7 days after treatment, there was active fibroplasia and angiogenesis (1) adjacent to 
the necrotic dermis (2). There was early epidermal reepithelialisation (3) adjacent and subjacent to 
the necrotic eschar (4). Sheep skin; haematoxylin and eosin stained section. Bar = 498µm. 
Magnification = 200x. 
 
Figure 13: Complete reepithelialisation (1) with overlying eschar, and dermal fibrosis (2) at 28 days 
after treatment. Note the rare diminutive adnexal unit (3). Sheep skin; haematoxylin and eosin 
stained section. Bar = 498µm. Magnification = 200x. 
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Figure 14: Schematic presentation of median scores of microscopic changes in the superficial skin 
(epidermis, upper hair follicles and sebaceous glands) and deep skin (lower hair follicles, apocrine 
glands and subcutis) layers of 6 sheep after treatment with SLS in the main study. Pre-existing mild 
inflammation and absence of fibrin was observed in the superficial skin layer. Similar scores were 
noted for angiogenesis and fibrosis (which led schematically to their merging and the loss of 
angiogenesis) in both skin layers.  
 
Figure 15A: Schematic presentation of mean scores and standard deviation of microscopic changes 
(necrosis, inflammation, reepithelialisation and fibrin) in the superficial skin (epidermis, upper hair 
follicles and sebaceous glands) and deep skin (lower hair follicles, apocrine glands and subcutis) 
layers of 6 sheep after treatment with SLS in the main study. Pre-existing mild inflammation and 
absence of fibrin observed in the superficial skin layers. Figure continues on to the next page. 
 
Figure 15B: Schematic presentation of mean scores and standard deviation of microscopic changes 
(angiogenesis, fibrosis and collagen) in the superficial skin (epidermis, upper hair follicles and 
sebaceous glands) and deep skin (lower hair follicles, apocrine glands and subcutis) layers of 6 
sheep after treatment with SLS in the main study. Similar scores were noted for angiogenesis and 
fibrosis in both skin layers. 
 
Figure 16: Severe tissue necrosis characterized by accumulation of electron-dense granular necrotic 
debris including remnant of putative blood vessel or hair follicle with degenerate red blood cells or 
follicle epithelial cells respectively (A). Note the electron-lucent oedema fluid (B) in the 
extracellular matrix. 2 minutes after SLS treatment. Sheep skin, dermis; transmission electron 
microscopy section. Bar = 2µm. Magnification = 15,000x.   
 
Figure 17: Damaged blood vessel: endothelial cell (E) degeneration with electron-lucent 
cytoplasmic matrix and loss of organelles, vesicles and nucleus. There is segmental disruption of 
the endothelial basement membrane (BM) with loss of pericytes and smooth muscle cells. The 
extracellular matrix (ECM) contained fragmented and disorganised collagen fibres. 2 minutes after 
SLS treatment. Sheep skin; transmission electron microscopy section. Bar = 200nm. Magnification 
= 15,000x. 
 
Figure 18: Early less damaged blood vessel: detachment of endothelial cells (E) from the basement 
membrane (BM) into the lumen. Degenerated cells contained cytoplasmic vacuoles. The chromatin 
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(C) is marginated. Note the preserved pericyte structure (P). 2 minutes after SLS treatment. Sheep 
skin, deep dermis; transmission electron microscopy section. Bar = 2µm. Magnification = 4,000x.   
 
Figure 19: Normal blood vessel which is lined by endothelial cells (E) containing an electron-dense 
nucleus and an outer pericyte (P) with a moderately electron-dense nucleus. Red blood cells (RBC) 
are noted within the lumen of the blood vessel. Untreated, control sheep skin, deep dermis; 
transmission electron microscopy section. Bar = 2µm. Magnification = 4000x. 
 
Figure 20: Lymph vessel with loss of the normal architecture. Note the irregular basement 
membrane (BM), degenerated endothelial cells (E) and disorganised and fragmented collagen fibres 
separated by oedema in the extracellular matrix (ECM). 2 minutes after SLS treatment. Sheep skin, 
deep dermis; transmission electron microscopy section. Bar = 5µm. Magnification = 6,000x. 
 
Figure 21: Normal, unaffected hair follicle at 2 minutes after SLS treatment. There is mild 
spongiosis (intercellular oedema characterised by small clear vacuoles) in the outer layer of the 
follicular epithelium (FE). The keratin (K), basement membrane (BM), extracellular matrix (ECM) 
and fibroblasts (F) are structurally normal. Sheep skin, deep dermis; transmission electron 
microscopy section. Bar = 10µm. Magnification = 2,500x. 
 
Figure 22: Severely degenerated hair follicle at 2 minutes after SLS treatment. A) Splitting and 
fragmentation of the follicular basement membrane (BM). No organelles or nuclear structure are 
evident in the necrotic follicular epithelial cell (FE). The extracellular matrix (ECM) is degenerated 
with collagen fibre fragmentation and oedema. Bar = 2,000nm. Magnification = 12,000x. B) A 
higher magnification showing fragmentation of the follicular basement membrane (BM), with 
oedema in the extracellular matrix (ECM). Sheep skin, deep dermis; transmission electron 
microscopy section. Bar = 500nm. Magnification = 40,000x. 
 
Table 1: Grading of histopathologic changes in sheep skin following SLS treatment in the sighting 
study. 
 
Table 2: Mean scores and standard deviations (in brackets) of gross skin appearance at different 
times after SLS treatment of 3 sheep in the sighting study. Gross changes of the treatment sites were 
subjectively scored as (0) normal, (1) mild swelling, <1.5 cm diameter; (2) moderate swelling, <2.5 
cm with redness, crusting or scab formation; or (3) severe swelling, >3.0 cm with blanching or 
redness.  
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Table 3: Mean values and standard deviations (in brackets) of clinical and behavioural parameters at 
specific time points after SLS treatment of 3 sheep in the sighting study. 
 
Table 4: Median grades of skin histopathologic changes at specific time points after SLS treatment 
of 3 sheep in the sighting study. 
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1. Flystrike and mulesing in sheep: A literature review 
 
1.1. What is flystrike (myiasis)? 
Myiasis (Greek myia = fly) is defined as “the infestation of live human and vertebrate animals with 
dipterous larvae, which at least for a certain period, feed on the host’s dead or living tissue, liquid 
body substances, or ingested food”.9 Myiasis infestation is commonly known as ‘strike’.4  
In sheep, flystrike or cutaneous myiasis is caused by ovipositing in tissues by the blowfly Lucilia 
cuprina (Diptera: Calliphoridae),
4, 10, 11
 resulting in ulcerative and exudative dermatitis associated 
with larval feeding activity and secretion of proteases.
12, 13
 Lucilia blowflies are primary facultative 
ectoparasites which do not completely rely on living hosts for completion of their life cycle; myiasis 
is initiated by gravid females attracted to skin soiled by urine and faeces, bacterial infection and 
suppurating wounds.
14
  
The breech region of sheep is predominantly affected by flystrike; however body strike is 
considered the main life-threatening form of myiasis caused by Lucilia blowflies.
15, 16
 Breech strike 
consists of two types: 1) crutch strike which extends from the tail base to the border of the udder or 
scrotum or 2) tail strike which involves the sides and stump of the tail.
17
 Body strikes generally 
incorporates the back, flank and withers (or shoulders). Among other factors, skin cuts after 
shearing, crutching or mulesing can increase the risk of strikes during periods of high blowfly 
activity.
18
 Blowfly strikes progress from covert (undetectable deposition of low egg mass) to overt 
when large egg masses are deposited in damaged skin.
19, 20
 
 
1.1.1. Blowfly species involved in flystrike 
The blowfly family, Calliphoridae can be divided into three functional groups based on their larval 
feeding habits: (1) saprophages which live in decaying organic matter and can secondarily invade 
existing infestations (i.e. secondary facultative species); (2) facultative ectoparasites which can 
initiate myiasis or live as saprophages (i.e. primary facultative species); and (3) primary obligate 
parasites which feed exclusively on tissues of living vertebrates.
14
 This functional division may 
reflect the progressive evolution of parasitism in the blowfly family.
9
 Evolution from saprophagy to 
facultative myiasis may have occurred with the domestication and spread of non-resistant livestock. 
18 
 
Phylogenetic analysis using 28SrRNA inferred an independent evolution from saprophagy to 
obligate parasitism and the ability to initiate myiasis in the Calliphoridae.
21
 
Lucilia are primary facultative blowflies, most often associated with opportunistic flystrike on 
Merino sheep whose breeding for desirable wool and conformational characteristics have given 
them features which predisposed to strike.
22
 In the twentieth century Lucilia cuprina Wiedemann 
(Diptera: Calliphoridae) was introduced into Australia, presumably from South Africa in the course 
of transporting sheep from Europe and North America.
23, 24
 DNA analysis confirmed that the 
blowfly was further dissipated into New Zealand.
25
 Now known as the Australian sheep blowfly, 
Lucilia cuprina is the primary cause of flystrike in sheep flocks surveyed, with reported incidences 
of 79% in Queensland
26
 and between 60 and 90% in New South Wales.
27
 Lucilia sericata can act as 
a primary myiasis fly but is generally restricted to more urban habitats. Other species of flies which 
may secondarily invade existing myiasis of sheep include Calliphora stygia, Calliphora augur
28
 
and Chrysoma rufifacies.
29
 
 
1.1.2. Pathogenesis of flystrike   
The Australian Merino sheep possess skin folds of dense fleece around the breech and body which 
predispose to moisture retention from urine and faeces. The wet wool predisposes to bacterial 
infection such as fleece rot (Pseudomonas aeruginosa)
30
 and dermatophilosis (Dermatophilus 
congolensis)
31
 and skin irritation which promotes blowfly strike.
32, 33
 Research findings implicated 
the important role of odours emanating from wool altered by urine and faecal contamination, 
flystrike or bacterial infection in attracting gravid female blowflies to oviposit on sheep.
34, 35
  
Once hatched from eggs, Lucilia larvae feed superficially on moistened or damaged skin; however 
with overcrowding they will begin to feed on deeper healthy tissue. Digestion occurs via secretion 
of amylase in the saliva and proteolytic enzymes in the larval excreta.
12
 Feeding occurs once the 
larval mouth hooks are firmly attached to allow alternating contraction and relaxation of the 
respective retractor and protractor muscles of the head, and subsequent maceration of the tissue. 
The larval feeding activity, in combination with secretion of proteases produces mechanical and 
chemical damage to the skin resulting in the development of flystrike.
12
   
The gross pathology of cutaneous myiasis involves multiple lesions of inflamed, ulcerated or 
damaged (eroded) skin, covered with matted wool which is associated with an offensive odour. 
Secretion of proteolytic enzymes by larvae leads to further skin damage, serous effusion and spread 
19 
 
of lesions.
13
 Consequently, sheep cutaneous myiasis caused by Lucilia blowflies produces a massive 
ulcerative and exudative dermatitis which is associated with serum drainage tracts and enlarged 
regional lymph nodes.  
The histopathology of cutaneous myiasis is characterised by ulceration and necrosis of the 
epidermis with marked neutrophilic infiltration and sero-cellular crusting. Non-ulcerated epidermis 
is hyperplastic with a thickening of up to tenfold. Healing of strike wounds progresses from a 
neutrophilic to mononuclear response from day 5 to day 13 including commencement of epithelial 
regeneration at day 7. Healing culminates in marked dermal fibrosis containing superficial gram 
negative and gram positive bacteria. Poorly resolved or slow healing wounds are commonly 
infected with Bacillus spp., Proteus spp., enterobacteriacae, streptococci and Pseudomonas spp..
13
 
 
1.1.3. Factors influencing the incidence of flystrike 
The incidence of sheep cutaneous myiasis by Lucilia blowflies is determined primarily by the 
interaction of risk factors contributing to flystrike susceptibility in sheep and the abundance of fly 
species involved.  
Australian Merino sheep are highly predisposed to flystrike as a result of breed susceptibility, 
extensive flock management with irregular inspections and warm climatic conditions.
36
 In 1883, the 
Vermont Merino sheep were introduced to breed with the Australian stock in an attempt to improve 
sheep size and wool productivity.
37
 As a result of this cross-breeding, the Australian Merino sheep 
possess a pair of vertical skin folds (or wrinkles) along each side of the perineal region for increased 
wool yield; these however predispose to moisture retention from urine and faeces which promotes 
blowfly strike.
32, 38
 Reports of significant flystrike outbreaks occurred after breeding of Merino 
sheep with the wrinkly skin genotype, which have led Sneddon and Rollin to identify the Merino 
skin wrinkles as a predisposing factor to blowfly strike.
38
  
Physical conformation such as wool fibre diameter can also influence sheep susceptibility to 
flystrike. Sheep with uniform fibre diameter were shown to be more resistant to fleece rot (infection 
by Pseudomonas aeruginosa) and body strike than those with variation in fibre diameters.
30
 Sheep 
with irregular fibre diameters may retain moisture in the fleece and become more susceptible to 
fleece rot than sheep with uniform fibre diameter. Resistance to fleece rot and body strike has been 
demonstrated in specific Merino sheep strains and bloodlines. This enables potential genetic 
selection either directly for body strike resistance or indirectly for fleece rot resistance.
39
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Tail length is another physical trait which can influence the incidence of sheep cutaneous myiasis. 
Sheep with a long woolly tail are more likely to develop breech strike than those with docked tails. 
Tail docking at the third joint level with the lowest point of the vulva (ewes) or anus (wethers) is 
ideal in reducing the incidence of breech strike
40
 and confers additional protection from sunburn 
and cancer.
41
 Ironically, tails which were docked too short can predispose sheep to tail strike and to 
a lesser extent breech strike
40
 due to the loss of ability for directing faeces outward and thus 
increasing the probability of soiling attractive to blowflies.
15
     
The incidence of blowfly strike is highly dependent on the weather and is likely to occur during 
periods of warmth and high humidity after rainfall
42
 in combination with increases in the rate of 
pasture growth and in the density and activity of gravid L. cuprina.
27
 In addition, wet weather 
increases the incidence of body strike associated with moist fleece and the development of fleece 
rot and/or bacterial dermatitis.
30, 31
 Breech strikes however can occur during dry periods of low fly 
abundance irrespective of weather conditions and are associated with diarrhoea caused by high 
worm burden as a result of grazing improved pastures and high stocking rates.
10, 15, 36
 Strike 
incidence can also increase independently of weather following sheep husbandry procedures which 
create wounds such as crutching, mulesing or tail docking.
27
  
In major sheep areas of south-eastern Australia, there is a long winter period of low fly abundance 
as L. cuprina larvae enter a state of arrested development in the soil (‘over-wintering’) and are 
subjected to high mortality rates of over 90%. Progression of life cycle resumes when soil 
temperature increases by 1.5ºC over a 4-day period and/or  when soil temperatures remain above 
11ºC for at least 7 consecutive days, resulting in the emergence of the over-wintering population as 
adult blowflies.
43
 As a result, blowfly strike in Australia occurs in a seasonal pattern over 
spring/early summer and autumn; however severe “fly waves” involving successive blowfly 
generations can develop once every 5 years when favourable weather conditions (warm, wet periods 
of high humidity) continue for extended periods of time.
44
  
The occurrence of overt or covert flystrike is influenced by the abundance of gravid L. cuprina. 
Mature female blowflies live for 2 to 3 weeks and lay 2 or 3 batches of up to 250 eggs when protein 
is freely available from carcasses, manure and existing strikes.
45, 46
 Under field conditions, 
proteinaceous material is rarely sufficient for complete ovarian development in female blowflies.
47
 
An overt blowfly strike is established from approximately 1500 larvae which emerge from 
cumulative egg laying by several flies. Larvae progress through 3 instars (developmental stages 
between successive moults before sexual maturity), grow to 10-15 mm in length in 3 days, drop off 
the sheep and burrow into the soil for pupation over 1 to 2 days before emerging as juvenile flies. In 
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less favourable conditions (dry periods of low humidity), maintenance of low level fly populations 
is achieved by breeding on carcasses or in small unnoticed, covert strikes commonly of the breech 
on a few sheep.
48, 49
 
 
1.1.4. Economic and welfare significance of flystrike 
Flystrike has a great economic impact as an infestation of livestock animals. Cutaneous myiasis 
caused by Lucilia blowflies negatively impacts on the welfare and productivity of the Australian 
Merino sheep, amounting to significant economic costs of AUD 280,000,000 annually.
1, 2
 Costs 
correlate predominantly with major disruptions to management operations on farms involving 
massive labour costs to control flystrike,
3
 followed by sheep morbidity and mortality, and loss of 
wool productivity.
4
  
Sheep farmers adopt a wide range of sheep husbandry and farm management practices which are 
often not well evaluated and labour intensive to prevent and treat blowfly strike; these measures can 
influence the timing of sheep shearing when their wool quality might not be optimal.
4, 24
 Prior to the 
availability of mulesing, flystrike management in Merino sheep involved frequent inspection once 
or twice weekly and crutching 3 or 4 times in a year. Enormous efforts were invested towards 
inspecting the entire paddock to ensure that fly struck sheep had not become separated from the 
flock or debilitated and were not being actively fed on by blowfly larvae.
50
  
Cutaneous myiasis lesions result in loss of skin barrier function and subsequent exudative loss of 
tissue fluid.
13, 51
 In its most severe form, flystrike can result in systemic disease including anaemia, 
hypoproteinaemia, septicaemia, toxaemia and disseminated intravascular coagulation.
13
 Merino 
wethers subjected to artificially-induced flystrike by Lucilia cuprina larvae have clinical signs of 
high body temperatures (of over 40ºC) and respiratory rates, accompanied with loss of appetite.
13
 In 
field situations, mildly infested sheep lose body condition and display signs of discomfort such as 
abnormal gait, excessive twitching, and bitting and rubbing of affected areas.
52, 53
 Severely affected 
sheep experience considerable losses in weight and fertility,
54
 pain, stress, isolation, inactivity and 
subsequent death if left untreated.
33
  
From a welfare perspective, identification of flystruck sheep through regular monitoring of the flock 
enables rapid treatment, reduction of animal suffering and circumvention of death.
50
 Treatment of 
flystruck sheep consists of shearing the affected areas of dark wool patches and the surrounding 
wool in order to allow drying of the wound, and removal of blowfly larvae. Topical application of 
22 
 
fast acting dressing (such as Ivermectin, Spinosad or Propetamphos) ensures larvae are killed and 
allows healing without repeat occurance of wound strike.
52
 Treated sheep are monitored during the 
recovery process. Additional insecticide application (jetting or backlining) offer long-term flystrike 
protection in treated and susceptible sheep. Treatment constitutes a major component to the cost of 
managing sheep flystrike, and includes extensive labour involvement such as crutching, mulesing, 
and mustering for insecticide application
3
 all of which are stressful to sheep.  
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1.2. Mulesing (The Mule’s operation) 
Mulesing became the preferred method of controlling cutaneous myiasis because of its effectiveness 
in rapidly reducing the risk of flystrike. Mulesing was widely adopted in the 1950s when wool 
prices peaked accentuating the economic loss to flystrike; and mulesing contractors became 
available.
55
  
In 1929, mulesing was developed by John H. W. Mules to prevent and control breech strike in 
sheep. Its purpose was to remove lateral skin folds from the breech area allowing tightening of the 
skin, reduction of wrinkles and expansion of the bare area. This in turn, minimized wool dampening 
by faeces and urine and thus reduced susceptibility to blowfly strike.
56, 57
 It was initially achieved 
using a knife to slice off perineal skin folds after the application of ‘Burdizzo’ clamps to essentially 
paralyse the nerve endings. Burdizzo clamps were later replaced with ‘Rolcut’ secateurs which 
removed skin folds with a crushing and cutting mechanism.
50
 However the frequent requirement for 
repeat treatments resulted in the implementation of a ‘modified mules operation’ which used 
mulesing shears to increase the bare area of the breech, leaving 2 crescent shaped scars; the tail was 
docked concurrently. The ‘radical mules operation’ then followed, which combined tail docking 
with extreme removal of skin from dorsal tail surface, and from between the tail and crutch. 
However this was found to predispose sheep to perineal cancer which resulted in the 
recommendation of leaving some wool on the surface of the tail.
50
  
The current ‘V’ mules operation (Figure 1) removes less skin than the radical mules operation and 
is conducted when fly density and activity is minimal.
58
 The operation involves the use of mulesing 
shears (sharpened, cleaned and disinfected) to remove two pieces of full-thickness skin from each 
side of the perineum, leaving intact a strip of skin from the vulva to the udder. Surgically the skin 
cut begins near the base of the tail, continues around the perineal area and back towards the ventral 
midline before extending caudally down the hind leg and ending in a sharp 'V' shape. Skin along 
each lateral side of the docked tail is also removed, leaving a ‘V’ shaped piece of skin over the 
dorsal, proximal one- to two-thirds of the tail.
58, 59
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Figure 1: Caudal aspect of sheep depicting the removal of skin (hatched) areas during mulesing (‘V’ 
mules) procedure; the tail is docked concurrently.
59
  
It is now accepted for mulesing to be performed concurrently with tail docking to 3 vertebral joints 
or to level with the base of vulva in lambs at 6 to 12 weeks of age, although the age can vary from 2 
weeks to 6 months.
59
 This is effective at reducing flystrike of the breech area and cancer caused by 
UV radiation,
60, 61
 and ultimately provides a high degree of lifetime protection against breech strike. 
Mulesed lambs are restricted in activity for up to four weeks and monitored every three days for 
compromises to the wound healing process; sheep are released once they are completely healed. 
Frequency of inspections increases with higher risks of flystrike. Lambs with infected wounds, 
which are abandoned and/or unable to walk are treated or euthanized with minimal disturbance to 
the remainder of the flock.
58
   
Wound healing after the ‘V’ mules operation is characterised grossly by a reduction in size of 
incision, appearance of granulation tissue and close apposition of surgical edges by day 32 after the 
procedure; resulting in a long linear scar over each side of the breech and tail.
62
 The visible 
tightening of skin folds in the breech and tail area increases the bare area of the breech and is ideal 
for prevention of blowfly strike, and provides a benchmark pattern of wound healing and 
contraction for mulesing alternatives to follow.  
Wound healing post-mulesing is characterised histologically by neutrophilic inflammation and 
immature granulation tissue from day 3, followed by reepithelialisation from day 6, mononuclear 
inflammation with mature granulation tissue and collagen fibres, and almost complete 
reepithelialisation at day 32.
63
 Lepherd et al. (2011) have also found a granulomatous inflammation 
around foreign bodies, resembling wool fragments in the mulesing wound bed. Wounds close to the 
vulva and along the sides and tip of the tail were slowest to re-epithialise, a finding attributed to 
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maximum tension and exposure of the surgical area. The previous and latter observations are likely 
to be important in field situations as they can complicate the wound healing process with persistent 
chronic inflammation and increased susceptibility to infection.
64
  
 
1.2.1. Implications of mulesing  
a. Benefits of mulesing 
Studies on mulesed sheep in Queensland, New South Wales, Western Australia and South Australia 
have shown a reduction in the incidence of breech strike by 81% to 100 %.
15, 57
 Mulesing results in 
a net benefit of AUD $100 – 130 million per annum from reduction in production losses and sheep 
mortality.
65
 
Apart from the prevention of breech flystrike, mulesing confers additional benefits of minimising 
the requirement for stressful handling procedures such as removal of stained wool or dags (breech 
wool that is contaminated with faeces), dipping and crutching, and enables simpler shearing.
65
 
Management of flystrike in mulesed sheep usually involves infrequent inspection and is therefore 
less time-consuming and less labour intensive than the management procedures adopted with 
flystrike in unmulesed sheep.
50
 
The surgical removal of skin wrinkles from the breech also indirectly improves reproductive 
performance in sheep. Rams with wrinkle-free breech have been shown to have superior fertility 
and semen quality due to their ability to regulate testis temperature in hot environmental 
conditions.
66-68
 In drought conditions, ewes with wrinkle-free breech demonstrated superior lambing 
performance with higher conception rates, more twins and lower birth associated mortalities.
69-71
   
In terms of cost-benefit analysis, mulesing reduces the cost of breech strike control by three to four 
fold through greater fertility of the breeding flock, and lower costs associated with crutching and 
wool loss to breech strike; thus optimising the price of wool sold.
72
 As mulesing shifts the focus 
away from management of flystrike, productivity in non-infested sheep is enhanced through timing 
of shearing for optimum wool quality, improved lamb growth and decreased mortality. Use of 
chemicals can also be reduced resulting in less residues in the wool. Mulesing can also lead to a 
reduction in the frequency of drenching for intestinal parasites which predisposes sheep to diarrhoea 
and consequently breech strike.
24
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b. Painful effects of mulesing 
The mules operation, combined with tail docking has been successful in reducing the risks of 
flystrike in sheep. However surgical mulesing is commonly performed without anaesthesia and 
analgesia, producing pain which is reflected by physiological and behavioural alterations in lambs 
post mulesing.
6, 56
  
Mulesing produces pain responses which are associated with increased levels of cortisol, 
interleukin-6, serum amyloid A and haptoglobin.
73
 Studies have shown that mulesing elevates 
cortisol substantially in the first 6 hours with persistence of response for up to 2 days,
74
 while β-
endorphin levels return to normal by 24 hours.
75
 Lambs subjected to mulesing, castration or tail 
docking demonstrated elevated cortisol concentrations, with concentration elevated for the longest 
period in the mulesed group.
75
 This finding is thought to occur due to the larger wound area created 
by mulesing relative to the other procedures.
59
  
Behavioural indicators of pain in sheep occurred up to 72 hours after mulesing and featured 
abnormal hunched up posture, increased periods of standing instead of lying or grazing, and an 
extreme fear of their handlers.
74, 75
  The fear response persisted for up to 114 days after the 
operation and was demonstrated by marked elevation in cortisol and β-endorphin levels at initial 
handling by the person who performed the mulesing procedure. Based on the premise of reducing 
fear response in operated sheep, it is recommended that mulesing be performed by contractors 
rather than by the regular sheep handlers.
74
 
Interestingly, physiological indicators of pain post mulesing were shown to impact less on sheep 
welfare when compared with those observed after flystrike. While mulesing causes an increase in 
cortisol of 43 ng ml
-1
 for up to 2 days, flystrike of a duration of 10 days in untreated sheep produces 
a cortisol increase of 70 ng ml
-1
.
76
 A quantitative risk assessment model compared the welfare 
outcomes of mulesing and flystrike using published measurements in cortisol, haptoglobin, 
bodyweight and behavioural changes, and demonstrated lower physiological and behavioural 
responses to mulesing than flystrike in Australian Merino sheep.
77
 Therefore mulesing definitely 
has an improved welfare outcome in comparison with flystrike in sheep. 
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1.2.2. The perceived need for mulesing alternatives 
Regardless of the results which promote mulesing as an effective means of saving sheep from 
blowfly strike in Australia, the operation is often seen as cruel, inhumane and unnecessary by 
animal rights and animal welfare activists. The alleged cruelty of mulesing has resulted in 
successful campaigns by US-based animal rights organisation, PETA (People for the Ethical 
Treatment of Animals) promoting the boycott of Australian wool by European and American 
clothing industries. In order to advocate welfare friendly wool products in the international market 
there has been an active search for less painful alternatives since the 1930s, and the proposal by the 
Australian Wool Innovation (AWI) to cease mulesing by 2010 if suitable alternatives could be 
found.
57, 78
   
There is currently a lack of alternatives which would allow mulesing to be phased out in the near 
future. The 2010 deadline proposed by the AWI could not have been achieved without an adverse 
animal welfare outcome associated with flystrike in sheep, particularly in grazing only flocks of 
fine-wool Merino sheep with the wrinkle phenotype. Until suitable alternatives are available, fine-
wool producers are adopting welfare based approaches to mulesing with the use of accredited 
contractors and pain relief. The use of local anaesthesia with mulesing at lamb marking will impose 
a small additional cost (AUD 0.50 to 0.80 per lamb) and labour, which are achievable welfare based 
outcomes.
78
 
The negative impact of painful mulesing on sheep welfare can be minimised by combining pre-
operative subcutaneous injection of long acting non-steroidal anti-inflammatory drug, carprofen 
with post-operative topical anesthetic treatment of the wound.
79
 In 2005, a spray-on local 
anaesthetic (Tri-Solfen®; Bayer Animal Health, Australia) became commercially available. Studies 
have demonstrated it is capable of providing wound analgesia for 24 hours, reduced pain-related 
behaviour and improved wound healing after mulesing, castration and tail docking in lambs.
78, 80
 
The reduction in pain responses was measured directly through assessment of wound sensitivity in 
combination with behavioural observations, digital photography, computer-assisted wound surface 
mapping
80, 81
 and wound thermography.
78
 
In addition to the existing sheep husbandry based options for the management of flystrike, extensive 
research is currently underway into the development of cost effective mulesing alternatives for the 
prevention of flystrike.  
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1.2.3. Mulesing alternatives in management of flystrike 
a. Husbandry based management strategies  
Immediate sheep husbandry based alternatives to mulesing involve an integrated management 
approach to flystrike control; however this can be impractical in that it is  labour intensive, costly 
and may rely heavily on chemical use. These alternatives to flystrike control are implemented 
during the ‘fly wave’ season extending from September to May,82 and include: 
Monitoring 
Increased monitoring of flock for signs of flystrike and subsequent treatment.
19, 53
 However even 
with regular  inspections, 10-15% of cases may be difficult to detect, and provide a reservoir for 
infection by L. cuprina.
19
 
Sheep Husbandry 
Crutching, dagging and shearing during periods of high blowfly activity may reduce moist fleece 
which attracts gravid female blowflies; Merino sheep have thick fleece which takes time to dry 
when wet. Shearing also improves efficiency of insecticide penetration to the skin.
83
 
Managing Diarrhoea 
Management of diarrhoea to control flystrike via drenching for intestinal parasites and providing a 
diet free from ryegrass and white clover.
84
 Diarrhoea can be managed by providing fibrous 
supplements to sheep grazing either improved pastures after rain-induced rapid grass growth or 
heavily grazed short pastures;
10
 and grazing sheep on pastures containing condensed tannins, 
Lotus corniculatus or Hedysarum coronarium, which bind protein and slows down digestion.
85, 86
  
Insecticides 
Strategic application of insecticides such as organophosphates (chlorfenvinphos, propetamphos, 
dichlorofenthion and diazinon) can provide 5 months of protection against non-resistant strains of 
L. cuprina but confer protection of less than 3 months against resistant strains.
87
 Difluorobenzon 
offers protection ranging from 58 to 170 days depending on dosage used and extent of flystrike 
risk.
88
 Long-acting insecticides such as insect growth regulators (cypromazine and dicyclanil) and 
macrocytic lactones (ivermectin) can protect sheep for 10 to 24 weeks.
89
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Flytraps 
Non-insecticidal flytraps were evaluated in Southern Queensland between 1999 and 2001, and 
were shown to reduce the incidence of flystrike by 38-55%.
90
 Flytraps have the potential to be an 
effective and environmentally sound measure for controlling L. cuprina.
24
  
For effective long term management of flystrike, the timing in conducting alternative control 
measures is crucial, and should aim to both target the blowfly population whilst minimising sheep 
susceptibility.
91
 High over-wintering mortalities in blowfly larvae potentiate the effectiveness of 
early insecticide application in spring before the emergence of adult flies, thus pre-empting the 
development of successive blowfly generations and reducing the risk of ‘fly wave’ associated 
strikes.
82, 89
 Insecticide treatment of sheep before blowfly emergence in spring to curb the expansion 
of  first generation L. cuprina is an effective management strategy,
89
 particularly in profitable wool 
production systems in south-eastern Australia where lambing occurs in spring and shearing occurs 
in either December or March.
92
  
Since prolonged wet weather increases the susceptibility of sheep to body strike secondary to fleece 
rot and dermatophilosis, local weather and climate data can be used to assess the risk of flystrike 
and assist with strategic implementation of a suitable management program to control blowfly 
population. Timing of shearing (with or without drenching) and prophylactic application of 
chemicals for maximum effectiveness can act synergistically to reduce sheep susceptibility and fly 
numbers respectively while addressing issues associated with insecticide resistance,
44
 wool 
residues,
93
 operator and environmental safety.
83
  
An alternative strategy involving genetically selecting sheep with reduced susceptibility to myiasis 
will take approximately 10 years to start having an effect.
59
 This involves slow, ongoing breeding 
for plain-bodied or breech-strike resistant sheep via genetic selection against breech wrinkle or 
more specifically genetic selection for sheep with a specific gene which delivers a range of factors 
such as plain body or bare breech and decreases the incidence of flystrike.
94
 Sheep are selected for 
low scores in key indicator traits including wrinkles, dags and breech cover. The rate of progress in 
genotype selection may be increased by breeding strategies involving low wrinkle sheep which are 
high performers for other relevant traits such as fertility and semen quality in rams or lambing 
performance in ewes.
71
 
Mulesing may not be necessary under low risk circumstances associated with improved selection 
and breeding for ‘fly and worm resistance’, where crutching occurs before shearing or where 
effective alternative strategies to prevent flystrike are available.
58
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b. Physical and chemical alternatives to surgical mulesing 
Plastic clips have been designed to physically alter the breech; these are clamped on the skin on 
both sides of the perineum and the tail causing ischaemic tissue necrosis. They fall off of their own 
accord 2 weeks after application.
59
 Pain response measured in clip-treated lambs showed moderate 
increases in cortisol and haptoglobin. In comparison values for similar parameters were 
substantially higher over a longer period in mulesed lambs. Behavioural responses were similar 
between the clip-treated and control lambs.
95
 Wound healing in clip-treated sheep was quick, 
however with a lesser wound bed contraction than mulesed sheep and a propensity for formation of 
skin tags and slippage of clips.
63, 96
 Field trials demonstrated an incidence of breech strike of 11.3% 
in clip-treated sheep, compared with 2.9% in mulesed sheep,
97
 which raises concern over the 
effectiveness of plastic clips in preventing flystrike.  
Many chemical alternatives to surgical mulesing have been tried but they are either ineffective at 
producing permanent wool removal or incur varying levels of discomfort in sheep. Chemical 
mulesing involves either topical or intradermal application of a specially formulated compound to 
the breech area of restrained sheep. Chemicals cause tissue necrosis and scab formation which 
sloughs off to leave a scarred area of stretched bare skin similar to the result of mulesing.  
Topical use of caustic phenol was discontinued due to compromised operator safety and sheep 
welfare.
98, 99
 Although intra-dermal or topical application of other chemicals such as less caustic 
quaternary ammonium compounds or collagenase showed promising results, the substantially 
increased cortisol levels with altered behaviours,
100, 101
 or delayed healing with increased 
susceptibility to flystrike
57
 imposed significant detriments to sheep welfare. 
Needleless intra-dermal applicators have been used to deliver doses of a formulated compound 
directly into prepared sheep skin.
63, 95, 102-104
 The needleless, pneumatically-powered applicator uses 
air pressure to drive the chemical through the skin and into the underlying subcutis.
105
 In 
comparison with conventional needle-based injections, needleless systems have the following 
benefits: 
105-107
 
1. Improved animal health via elimination of needle borne diseases. 
2. Speed and flexibility for large-scale injection programmes. 
3. Improved safety from needle stick injuries. 
4. Delivery of accurate drug dose into the tissue. 
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Needleless intra-dermal injection of 4% cetrimide (alkyltrimethylammonium bromide, a quaternary 
ammonium compound) into lambs
104
 and sheep
108
 with and without  pre-treatment of carprofen 
(long acting non-steroidal anti-inflammatory drug) resulted in physiological increases in cortisol 
and haptoglobin. However sheep pre-treated with carprofen displayed less abnormal postures of 
discomfort than the other groups. Wound healing was slower after intra-dermal centrimide in 
comparison with mulesing
63
 with reports of severe bruising,
109
 and marked initial swelling before 
subsequent formation of hard scabs with observed substantial purulent exudate beneath lifted 
scabs.
108
  Wound bed contraction was similar in mulesed and centrimide treated sheep.
96
   
Needleless intra-dermal injection of 7% sodium lauryl sulfate (SLS, an anionic surfactant) into 
lambs produced physiological increases in cortisol, haptoglobin, and neutrophil to lymphocyte 
ratio.
95
 However SLS treated lambs showed no abnormal postures of discomfort in comparison with 
the significant behavioural changes noted in mulesed lambs. A similar study confirmed that SLS 
treated lambs behaved similarly to the control group while their physiological responses were 
midway between those of the control group and those of the mulesed lambs which received post-
surgical topical analgesia.
102
   
Based on the improved welfare benefits following treatment, the current study was designed to 
investigate the suitability of intra-dermal SLS as a potential chemical alternative to mulesing. It is 
thought that intra-dermal SLS uses less chemical than topical treatments and because of quick 
destruction of hair follicles and sensory nerves would be more effective and cause less discomfort 
than mulesing or topical treatments.  
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1.3. Candidate chemicals for use in this study - anionic surfactants 
In this study, intra-dermal SLS was trialled as a potential chemical alternative to mulesing in sheep. 
Sodium lauryl sulfate, in addition to sodium tetradecyl sulfate (STS), is an anionic surfactant. These 
chemicals are composed of a hydrophilic, negatively charged head of sulfate anion attached to a 
hydrophobic, alkylated carbon tail. Anionic surfactants bind to most proteins with high affinity, 
resulting in protein unfolding, denaturation and inactivation.
7, 8
  
The rate of protein unfolding, denaturation and subsequent inactivation in anionic detergents is 
modulated by repulsion between detergent head-groups and anionic protein side chains, which 
occurs above the critical micelle concentration (cmc) of detergent in water.
7, 110
 A detergent’s cmc 
is the concentration of detergent above which monomers self-assemble into non-covalent 
aggregates (called micelles).
111, 112
 The cmc therefore dictates the amount of monomeric detergents 
required to solubilise proteins from cell membranes; using monomeric detergents at a concentration 
above the cmc invariably leads to loss of function in bound protein.  
SLS was chosen because of its low cost, wide commercial availability, and potential to be a 
chemically effective alternative to mulesing. The effects of SLS have been extensively studied in-
vitro and in-vivo, although only within the epidermis
113, 114
 and oral epithelium;
115, 116
 there is 
limited information published on the effects of SLS within the dermis. However SLS is chemically 
related to STS (sodium tetradecyl sulfate) which is used for sclerotherapy in human medicine and 
therefore has well documented effects within the dermis.
117-119
 The effects of both SLS and STS 
will be reviewed separately in the following sections.  
 
1.3.1. Sodium lauryl sulfate (SLS) 
Sodium lauryl sulfate (SLS), also known as sodium dodecyl sulfate (SDS), is used as an emulsifier 
in many pharmaceutical products including cosmetics, detergents, and toothpastes.
120
 SLS has a 
chemical formula of C12H25NaSO4 and consists of a chain of 12 carbon atoms (hydrophobic or 
lipophilic) attached to a sulfate group (hydrophilic), giving it the amphiphilic (having both 
hydrophilic and hydrophobic) properties required of a detergent (CAS No: 151-21-3).
121
 For the 
purpose of this study, SLS is an attractive candidate chemical alternative to mulesing given its in-
vitro and in-vivo effects, with the ability to cause cell necrosis through protein denaturation.  
In-vitro studies have shown that cell membrane protein unfolding, denaturation and inactivation 
occurs above the critical micelle concentration (cmc) of SLS at 7mM in water.
7, 122
 Under 
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conditions of low pH and high ionic strength (>200 mM NaCl) more cylindrical micelles are able to 
wrap themselves around the protein in the transition state, favouring binding followed by protein 
unfolding, denaturation and subsequent loss of function.
7
  
In-vivo studies demonstrated epidermal necrosis and dermatitis in rats and humans exposed to 
topical SLS. Important ultrastructural findings included severe necrosis of the basal layer of the 
epidermis with loss of the dermo-epidermal junction, and marked infiltration of neutrophils.
113, 114
 It 
is postulated that SLS ruptures the intercellular junction which can predispose to tissue necrosis, 
ulceration and inflammation.
123
 Given the effect of severe epidermal necrosis from topical SLS, we 
can postulate a similar effect of dermal necrosis in association with intra-dermal treatment; the 
subsequent destruction of hair follicles and nerves would make SLS a potential candidate for a less 
painful chemical alternative to mulesing.  
 
1.3.2. Sodium tetradecyl sulfate (STS) 
Sodium tetradecyl sulfate (STS) is chemically related to sodium lauryl sulfate but has two 
additional carbon molecules, C14H25NaSO4 (CAS No: 139-88-8).
121
 Intravenous STS is used as a 
sclerosing agent in the treatment of varicose veins
124, 125
 and haemorrhoids.
126, 127
  
Inadvertent extra-vascular injection of more substantial quantities of STS is an infrequent 
complication of sclerotherapy and may produce a shallow ulcer which is usually painless and heals 
in several weeks.
119
 Studies in rats using intra-venous and peri-venous injections of STS have 
resulted in severe inflammation, necrosis and subsequent fibrosis of the tissues surrounding the 
sclerosed vein.
128
 The damaged nervous and muscular tissue was accompanied with marked 
infiltration of neutrophils and necrosis of the arterial wall and muscle after 48 hours and 7 days 
respectively. Peri-venous inflammation and fibrosis after intravenous STS is partly explained by 
extravasation of the sclerosing agent after the injection.  
Intra-dermal and subcutaneous injection of 3 % STS has been associated with marked tissue 
necrosis and ulceration,
117, 129, 130
 with ulceration being less frequent following subcutaneous 
injection. Intra-dermal injection of STS into ears of mice resulted in ulceration and necrosis of the 
epidermis, dermis, subcutis and muscle, with moderate infiltration of neutrophils at 24 hours. 
Fibroplasia occurred at 4 days with accumulation of mononuclear cells including foreign-body giant 
cells in the dead muscle; epidermal hyperplasia was moderate at the margin of the ulcer. At 8 days, 
granulation tissue was marked with sloughing of necrotic epithelium. Complete reepithelialisation 
occurred at 14 days.
117
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Assuming that SLS behaves similarly to STS we can postulate that intra-dermal SLS causes skin 
necrosis, scab formation and eventually scar tissue. The end result is similar to that of mulesing 
where by scarring stretches the bare area of the breech and therefore minimises faecal and urine 
staining which predisposes to flystrike. In this sense, intra-dermal SLS is thought to cause 
destruction of hair follicles and sensory nerves in the skin and would potentially result in an 
effective chemical alternative which is less painful than surgical mulesing in sheep. In order to 
better understand the mechanisms and mode of action of SLS in treated skin, a brief overview of the 
anatomical and histological features of sheep skin and the processes which characterise wound 
healing is provided in the following sections.  
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1.4. Sheep skin 
 
Sheep skin, as that of other species can be divided into epidermis, dermis, and subcutis. The 
epidermis comprises of a basal epithelium which differentiates into the outermost cornified 
epithelium. The dermis contains hair follicles and associated adnexal glands (sebaceous and 
apocrine glands). The dermis can be subdivided into the superficial dermis which consists of upper 
hair follicles and sebaceous glands, and the deep dermis which contains lower hair follicles and 
apocrine glands.
131
 A network of blood vessels and capillaries supply the dermis, epidermis and 
dermal papillae. 
 
Compound hair follicles characteristically populate the dermis of sheep. These comprise of primary 
and secondary follicles (Figure 2). Primary follicles have sebaceous glands, apocrine glands and an 
arrector pilli muscle while the secondary follicles have only sebaceous glands. A typical compound 
hair follicle contains three primary follicles and a number of secondary follicles. In Merino skin, a 
compound hair follicle bundle contains up to nine follicles which open into a common orifice.
132
 
 
                            
Figure 2: Sheep skin showing a compound hair follicle (CHF) with a primary follicle (PF) and 
associated arrector pilli muscle (APM), sebaceous gland (SG) and apocrine gland (AG), and 
secondary follicles (SF). Haematoxylin and eosin stained section. Bar = 502µm. Magnification = 
400x. 
Epidermis 
Superficial 
dermis 
Deep 
dermis 
Subcutis 
502 µm 
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The cutaneous nerve plexus occupies the deep dermis, and consists of mingling sensory and 
autonomic (motor) nerve fibres. Sensory fibres from the cutaneous plexus ascend to terminate on 
hair follicles, in the superficial dermis, and in the epidermis. In the absence of necrosis, epidermal 
hyperplasia induced by chemical and physical injuries is associated with a proliferation of sensory 
nerve fibres in the epidermis. These fibres are too fine to be impregnated with silver and detected by 
light microscopy.
133
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1.5. Wound healing 
 
Gantwerker and Hom state that “the process of wound healing is a dynamic, complex interplay of 
cytokines, involving many different cell types”.134 In-vitro studies confirmed the importance of 
cytokines as signalling molecules during the healing process. Over 30 cytokines are involved in 
wound healing, produced by macrophages, platelets, fibroblasts, epidermal cells and neutrophils.
135
 
Wound healing can occur by primary or secondary intention. Primary healing involves 
uncomplicated healing of non-infected and closely-approximated wounds while secondary healing 
of open wounds occurs by reepithelialisation, granulation and contraction, which is susceptible to 
complications such as infection and poor healing.
134
 The wound healing process also depends on the 
extent of necrosis of the epidermis, dermis and adnexa, and disruption of the basement membrane. 
Severely damaged skin heals with extensive inflammation, granulation tissue and wound 
contraction. Wound healing (Figure 3) can be divided into three overlapping stages over time:
134, 136-
140
  
1. Haemostasis and inflammation  
2. Reepithelialisation, fibroplasia and angiogenesis (proliferation)  
3. Wound contraction and collagen production (remodelling)  
 
           
Figure 3: The sequence of events in normal wound healing which involves the overlapping stages of 
haemostasis, inflammation, proliferation and remodelling; adapted from Ginn et al, 2007.
138
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Disruption of blood vessels at the site of tissue injury results in extravasation of blood constituents 
and formation of a blood clot (haemostasis); platelets secrete growth factors and chemokines which 
recruit inflammatory cells.
136, 141
 However in the absence of haemorrhage, platelets are not 
involved; instead injured parenchymal cells in conjunction with the coagulation and activated 
complement pathways generate numerous vasoactive mediators and chemotactic factors which 
recruit inflammatory cells to the site of injury.
136
 Neutrophils and macrophages promote 
phagocytosis and tissue debridement; macrophages are also pivotal at initiating granulation tissue 
formation and releasing a variety of pro-inflammatory cytokines and growth factors.
141
  
 
Inflammation encapsulates the reaction of vascularised tissues to local injury and incorporates a 
series of changes in the terminal vascular bed, blood, and in the connective tissues. It is a process 
which aims to eliminate the irritant and to repair the damaged tissue.
142
 Acute inflammation 
produces ultrastructural changes in blood vessels characterized by swelling of endothelial cells with 
increased density of their tight junctions due to thickening of basement membrane and increased 
amounts of surface glycoproteins. Injured basement membranes of blood vessels and epithelial 
structures are distorted and discontinuous enabling movement of fluid and cells into tissues, and 
protein-containing fluid to escape into extravascular spaces respectively.
143
 Serum leakage in 
combination with protein and cells of the inflammatory reaction contribute towards the formation of 
a surface eschar (scab) at the ulcerated wound site of the epidermis.
144
  
 
During the proliferative phase, epithelial cells multiply at the wound edges before migrating under 
the scab (reepithelialisation). The stratum basale, hair follicles and their associated sebaceous 
glands contain epithelial stem cells which can regenerate and differentiate into basal keratinocytes, 
an essential process of reepithelialisation.
144-148
 Fibroblasts migrate into the wound, differentiate 
into myofibroblasts and lay down disorganized collagen; angiogenesis occurs simultaneously.
149
 
Fibroplasia and angiogenesis emanate from remnant dermis and subcutis including dermal sheath 
fibroblasts around hair follicles, pericytes around blood vessels, smooth muscle cells and 
fibrocytes.
150
 
 
During tissue remodelling, most of the endothelial cells, macrophages and myofibroblasts undergo 
apoptosis (programmed cell death) or exit from the wound. Over 6-12 months the acellular 
extracellular matrix is remodelled from type III collagen to type I collagen,
151
 which strengthens the 
repaired tissue to up to 80% of the original tensile strength.
152
 Wound contraction occurs most 
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extensively near the wound surface; the reepithelialised wound (scar) is slightly raised above the 
surrounding surface and does not contain normal skin appendages.
153
  
 
It is postulated that sodium lauryl sulfate (SLS) behaves similarly to sodium tetradecyl sulfate 
(STS). Intra-dermal SLS treatment of the breech would cause necrosis of skin structures including 
hair follicles and sensory nerves, followed by scab formation with eventual scarring and stretching 
of the bare area which reduces susceptibility to flystrike. Consequently the hypothesis of this 
project focused on the potential of intra-dermal SLS as an effective and less painful chemical 
alternative to mulesing by investigating the effects of intra-dermal SLS treatment via its mode of 
action, time sequence of tissue damage and healing in sheep skin; treated animals are observed for 
changes in behaviour, appetite and weight gain indicative of discomfort. 
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2. Aims of Research 
 
Intra-dermal sodium lauryl sulfate (SLS) is an attractive candidate as a chemical alternative to 
surgical mulesing given its ability (in-vivo and in-vitro) to cause cell necrosis through protein 
denaturation in membranes,
113, 114
 and the reduction of behavioural changes associated with 
discomfort after treatment in sheep
95, 102
. This forms the basis of the current thesis which 
investigates the welfare outcomes including behavioural responses to pain, and characterises the 
macro- and microscopic changes caused by intra-dermal injection of SLS into sheep skin. Research 
findings will confirm the mechanism of action of SLS on all skin structures, particularly adnexal 
units and sensory nerves, and its potential as an effective and less painful chemical alternative to 
replace surgical mulesing. 
 
This study aims to investigate the effects of intra-dermal SLS in sheep skin by: 
1. Studying the time sequence and nature of SLS induced tissue damage and repair using 
histopathology and transmission electron microscopy and comparing these to published 
studies on mulesing.  
2. Hypothesizing the possible mode of action of SLS within sheep skin and its effect on 
structures of interest. 
3. Observing the effect on productivity and nature of behavioural changes that may indicate 
discomfort associated with the procedure 
 
Objectives 1 and 2 will be achieved by grading the gross and histopathologic changes which occur 
in the skin after treatment. Ultrastructural assessment of skin tissue damage using transmission 
electron microscopy will be conducted in the early phase after treatment in order to provide 
morphological information supporting the hypothesis of the possible mode of action of SLS.  
 
Assessment of pain and discomfort in SLS-treated sheep will be based on observations for 
immediate and delayed changes in behavioural parameters such as agitation and unresponsiveness 
respectively. Pain will also be assessed from productivity changes such as general appetite; body 
weight gain will be monitored in the main study. 
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2.1. Study design 
 
This study involved a total of 12 plain bodied Merino sheep which were of the same age and sex; 9 
sheep were allocated for the experiments while additional sheep were reserved as replacements 
should anything happen to the original sheep to preclude their involvement in the study. The 
untreated animals served as negative controls. Three sheep entered a preliminary sighting study to 
assess the underlying changes following manual intra-dermal injection of sodium lauryl sulfate 
(SLS) over a period of 7 weeks. Six sheep entered the second phase of the study (main) using the 
working parameters established from the sighting study and sampling conducted around the times 
of greatest interest. This study focused on qualitative rather than quantitative research, in which we 
were not trying to quantify the percent efficacy of the SLS treatment. The focus of the work was on 
understanding the pathological effects of the intra-dermal treatment by intensive study of a few 
animals. Preliminary results from the sighting study instigated the replacement of needle injections 
with a needleless system for intra-dermal administration of SLS in the main study. 
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3. Sighting Study  
 
Mulesing, generally performed at lamb marking involves surgical removal of skin from the breech 
to provide a stretched depilated area that prevents urine and faecal soiling, and is therefore less 
conducive to blowfly strike. The procedure is generally performed without anaesthetic and is 
perceived as painful and cruel by animal rights activists, resulting in the search for a painless yet 
effective alternative by the Australian Wool Industry. 
  
The sighting study aims at trialling intra-dermal SLS as a candidate chemical alternative to 
mulesing by assessing its effect on healing, scaring and depilation in the skin, while addressing 
whether it has any painful impact on the general behaviour and appetite of sheep. The histological 
confirmation of a depilation and denervation process following treatment would allow the use of the 
chemical in a main study and to further validate its usefulness in field application as a non-surgical 
and less painful substitute to mulesing. 
   
Three sheep entered an initial sighting study conducted over a period of 7 weeks to assess the 
underlying process and outcome of manually injecting SLS into skin sites on the flank. Optimal 
working parameters and biopsy times when histopathology of interest occurred were established in 
the sighting study; these data were applied towards the design of a larger main study.  
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3.1. Methods and materials 
 
 
3.1.1. Preparation of sheep 
 
This study was approved by the University of Queensland Animal Ethics Committee (approval 
number SVS/567/06). 
 
Twelve plain bodied Merino sheep wethers (neutered males) of approximately 6 months of age 
were sourced from the same supplier; three and six sheep were allocated for sighting and main 
study respectively. The additional sheep were reserved as replacements for the original sheep 
should any be excluded from the study and also served as controls.  Purchased sheep were allowed 
to acclimatise to their yarded environment for a week before the commencement of experimental 
studies. A week before the trial, sheep for the sighting study were housed in pairs with their 
untreated cohorts, on wire floor under cover; this housing was maintained for the duration of the 
study. They were fed 250 g of calf pellets per head twice a day, supplemented with ad libitum 
lucerne chaff, and had free access to water. The sheep were weighed and physically examined to 
confirm a healthy status. 
 
A small sample size of three animals was chosen for the sighting study with the justification that 
results could be generated quickly and used to design a larger main study.
154, 155
 The length of trial 
period was chosen based on previous studies which reported wound healing occurring between 2 
and 4 weeks after topical application of a patented caustic chemical.
57
 Because of the small sample 
size in this qualitative sighting study, it was accepted that the generation of strong, statistically 
robust conclusions would not be possible based on the results obtained. 
 
 
3.1.2. SLS treatment and skin biopsy 
 
Any mulesing alternative would ideally be used on the breech area however the flank instead of the 
breech was the chosen site of treatment in this study because it offered a wide area of skin for 
sequential biopsy after SLS treatment at specific time intervals. Wool of these sheep was shorn 
down to 1 cm in length over the treatment sites on both sides of the body. These sheep were 
weighed and fasted for 12 hours before the trial. Intramuscular injection of a sedative (1 mg/kg 
Xylazine; Xylazil-20, Ilium Veterinary Products, Smithfield, NSW) and subcutaneous injection of 
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a narcotic analgesic (0.005 mg/kg buprenorphine; Temgesic, Reckitt Benckiser, West Ryde, 
NSW) were administered to each sheep 5 minutes before the start of the trial. 
 
When the sheep were lightly sedated, as gauged by onset of recumbency, they were positioned on 
their side with the head up and hindquarters lowered on the surgical table. This prevented 
abdominal contents pushing onto the diaphragm and interfering with respiration. Regurgitation was 
not an issue as the sheep had an intact swallowing reflex. The shorn areas were cleaned with 1% 
chlorhexidine solution (Chlorhex-C®; Jurox, Rutherford, NSW) prior to marking of treatment sites 
with a permanent marker (indelible pen). Skin adjacent to individually marked treatment areas was 
anaesthetised with an inverted L-block series of injections using 1 ml of local anaesthetic (20mg/ml 
or 2% Lignocaine-20, Ilium Veterinary Products, Smithfield, NSW) at 2 cm dorsal and cranial to 
the treatment site. This was achieved by inserting a long needle to its full depth and injecting the 
local anaesthetic solution steadily as the needle was withdrawn. Skin desensitization occurred after 
2 minutes and was confirmed by a skin prick test prior to intra-dermal SLS treatment and biopsy.  
 
Treatment sites were small and evenly spaced in order to prevent cross reactions. There were a total 
of 10 treatment sites each separated by a distance of 5 cm, and divided into two rows on each of the 
left and right sides of the flank. Individual treatment sites consisted of a grid of 2 x 2 squares each 
receiving 0.2 ml injections (total of 4 injections) separated by a distance of 1 cm (see diagrammatic 
representation in Figure 4). Intra-dermal injections containing a solution of SLS (7% 
weight/volume) and benzyl alcohol (20 mg/ml) in phosphate buffer and water for injection 
(formulated by Cobbett Technologies Pty Ltd)
156
 were administered using a 1-ml hypodermic 
syringe and a 25-gauge needle to provide a calculated SLS dose of 14mg/cm
2 
per treatment area. 
The treatment area was designed to mimic that of the needleless applicator, SkinTraction® 
developed by Cobbett Technologies, which has a nozzle head consisting of 4 delivery tubes 
arranged in a grid and separated at a distance of 10 mm (see Figure 8 in next chapter, the main 
study). Investigations into the optimal SLS concentration
157
 and mode of delivery to provide 
effective and rapid protein denaturation were established in previous trials by Cobbett 
Technologies. A novel applicator, SkinTraction® for needleless intra-dermal delivery of the 
chemical was developed during these trials.
158
 These research findings have been acknowledged in 
online publications by the Australian Wool Innovation.
159-161
  
 
Aqueous SLS formulation was delivered by inserting the needle with the bevel facing up, under the 
skin at approximately 70º angle. The dermis offered some resistance in comparison to the 
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subcutaneous tissue, thus ensuring that the injections were administered at the right level in the 
skin. One area was left untreated to provide a negative control. 
 
 
 
 
 
 
 
  
 
Figure 4: Diagrammatic representation of 10 treatment sites each separated by a distance of 5 cm 
and composed of a 2 x 2, 1-cm
2
 grid area to receive 4 intra-dermal injections. Treatment sites were 
organized into 2 rows on each sides of the flank of the sheep involved in the sighting study. Skin 
biopsies were taken from the centre of individual treatment sites.  
 
Skin desensitization using an inverted L-block injection of 1 ml of local anaesthetic (Lignocaine-
20, Ilium Veterinary Products, Smithfield, NSW) was administered and tested by skin prick prior 
to the biopsy procedure. A sterile disposable biopsy punch (8 mm diameter) was used to serially 
sample from the centre of each of the untreated (negative control) and SLS-treated skin at 2, 5, 10, 
15, 30 minutes; 1, 2, 4, 6 hours and 1, 2, 3, 4, 7, 10, 14, 21, 28 days. From day 1 onwards, sheep 
were sedated and manually restrained by a second person during the process of local anaesthetic 
administration and skin biopsy. The punch biopsy was performed by downward rotation through the 
epidermis, dermis and subcutaneous fat, producing a cylindrical core of tissue. Skin biopsy 
specimens were fixed immediately in 10% neutral buffered formalin for histological assessment 
under light microscopy. Tissues were transferred gently using Adson’s toothless forceps to 
minimize crush or compression artefact.
162
  
 
Following the biopsy procedure, each site was topically treated with an antibacterial fly repellent 
(Extinosad aerosol, ELANCO Animal Health, West Ryde, NSW). Suturing after biopsy was not 
performed due to the small size of the wound which healed quickly. An intramuscular injection of a 
long acting antibiotic (5mg/kg Oxytetracycline, Engemycin-100, Intervet, Bendigo East, VIC) 
was given on day 4 after treatment to minimise potential wound infection which can delay and 
complicate the healing process. 
 
 
  Row 1                                                                                                                                    
  Treatment site:         1                   2                   3                   4                   5 
 
  Row 2                                                                                                                                    
  Treatment site:         6                   7                   8                   9                  10 
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3.1.3. Assessment of SLS-treated sheep 
 
After the initial treatment phase, sheep were moved back into the pen where they were kept in pairs 
with their untreated cohorts and observed for at least 30 minutes. Once recovered from sedation, 
sheep were subjected to further assessments. The following clinical and behavioural parameters 
were recorded for each treated sheep: 
 General demeanour: (1) bright, alert and responsive, (2) hyperactive/restless, (3) depressed, 
and (4) coma; 
 Movement and posture: (0) normal, (1) biting/rubbing/skin twitching of treated sites, (2) 
arching back, and (3) head drooping; 
 Gait and coordination: (0) normal, (1) ataxia, (2) paresis, (3) paralysis; 
 General appetite or interest in food: (0) normal or (1) abnormal; 
 Rectal temperature (°C); 
 Heart rate (per minute); 
 Respiratory rate (per minute); 
 Mucous membrane colour (1) pink, (2) pale or (3) otherwise; 
 Capillary refill time; 
 Changes in the gross appearance of un-biopsied treatment site such as discolouration, 
swelling and scab formation were subjectively scored as (0) normal, (1) mild swelling, <1.5 
cm diameter; (2) moderate swelling, <2.5 cm with sero-cellular crusting or scab formation; 
or (3) severe swelling, >3.0 cm with blanching or redness. 
 
Clinical parameters from previously fasted sheep were taken before sedation and skin 
desensitization at each biopsy procedure. Treated sheep were monitored every 4 hours on the first 
day, then daily for four days, followed by observations on the designated days for biopsy. Sheep 
were also observed for 30 minutes after each biopsy procedure to ensure that there was no excessive 
bleeding from the sampled site and there was complete recovery from sedation. Fully recovered 
sheep were released into a holding pen with their untreated companion animals. Sheep were given 
free access to water and 250 g of pelleted calf feed per head at 20 hours after the entire process of 
fasting, treatment procedure and recovery phase. Observations for behavioural patterns and appetite 
(feed or water preference) were made simultaneously from treated and untreated sheep over a 30 
minute period every 4 hours on the first day, then daily for four days. 
  
Behavioural indicators have been useful in defining pain responses in lambs following husbandry 
procedures which themselves generate different magnitudes of pain responses based on the amount 
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of tissues involved and the degree of innervation at the site.
11, 163, 164
 The responses to pain and 
discomfort in sheep after SLS treatment were assessed based on the following reported observable 
changes in the behaviour patterns after surgical manipulation: 
1) Behaviours of agitation within 48 hours. Studies have shown that immediately after painful 
procedures (tail docking and castration), lambs displayed agitated behaviours which were 
rarely seen normally such as increased pacing, stamping, restlessness (getting up and 
down),
165
 writhing and licking or biting the site of damage.
166
 
2) Behaviours of unresponsiveness after 48 hours. After a period of unsuccessful agitated 
responses to “escape” from pain, sheep will resort to behaviours of unresponsiveness or 
immobility
167
 such as statue-standing, stilted gait and inert lying postures.
163
 For example, 
sheep displayed hunched-up posture and increased periods of standing on the third day after 
they were mulesed.
74, 75
  
Behavioural assessment of pain can be confounded by a phenomenon known as ‘predator-induced’ 
analgesia.
168
  Predator avoidance is a high priority behaviour; humans are viewed as predators and 
their presence will hold an animal’s attention and might temporarily displace awareness of pain.167 
The impact of this phenomenon was minimized in the sighting trial by observing sheep from a safe 
distance (approximately 30 meters), where human presence was not perceived as a threat.  
 
 
3.1.4. Histopathologic assessment of skin biopsy specimens 
 
Each skin biopsy specimen was fixed in 10% neutral buffered formalin. Fixed tissues were placed 
in cassettes, processed by dehydration and clearing in an automated tissue processor (Shandon 
Excelsior) and embedded in paraffin. Paraffin embedded tissues were sectioned at 5 microns 
thickness by a microtome. Cut sections were floated on a warm (40C) water bath to remove 
wrinkles and picked up on a glass slide. Glass slides were placed in a warm (60C) oven for 30 
minutes to help the section adhere to the slide. Tissue sections on slides were stained with 
haematoxylin and eosin (H & E) in an automated staining machine. Sections were finally dried in 
preparation for mounting. A glass cover-slip was glued onto the tissue section using mounting 
media to provide better optical quality viewing under the microscope.
169, 170
 Slides with sections of 
tissue necrosis accompanied with multifocal clusters of fine granular basophilic material were 
stained with von Kossa, a histochemical staining method for calcium. In this method, tissue sections 
treated with a silver nitrate solution allowed silver deposition by replacement of calcium reduced by 
exposure to strong light and therefore visible as metallic silver.
169, 170
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Histopathologic changes noted and assessed within the skin layers (epidermis, dermis and subcutis) 
included parameters such as epidermal sloughing, inflammation, haemorrhage, oedema, necrosis 
and fibrosis. Refer to Table 1 for description of the grading criteria for histopathologic change. 
Assessment of histological changes was made from areas with the most severe changes. A 4 point 
grading system was used to score each lesion parameter subjectively as a percentage of tissue 
change within 10 high powered fields (400x) using 5x5 grid under light microscopy:  
a) Grade 0, normal (0%);  
b) Grade 1, mild (>0-33%); 
c) Grade 2, moderate (>33-66%); and 
d) Grade 3, severe (>66-100%).  
 
Descriptive histopathologic assessment of each specimen was also performed. In order to remove 
potential observer bias, grading of the H & E stained sections was performed blind without 
knowledge of the origin of the specimens. This provided a comprehensive method of masking (or 
blinding) tissues for histopathologic examination and involved labelling of individual samples (e.g. 
1, 2, 3, 4, etc.) without background information or reference to treatment group.
171
 Once the H & E 
stained sections were graded and their origins revealed, the mean scores from 10 high powered 
fields for each histopathologic change were calculated per sheep at each time point and the median 
grades for all three sheep were tabulated. The median was used because of the small sample size 
and accommodated for factors which impeded scoring (e.g. tissue necrosis or insufficient tissue on 
sampling); it showed the midpoint value and eliminated outliers or extreme scores.
172, 173
  
 
The small sighting study had limitations in terms of making statistical inference (e.g. confidence 
intervals and P-values) with the probability of producing false-positive results or over-estimating 
the magnitude of an association.
155
 It therefore precludes accurate interpretation of the statistical 
significance of results. The Harmonization of Nomenclature and Diagnostic Criteria (INHAND) 
have recommended that pathologists rely on their morphologic interpretation of lesions 
preferentially over statistical inference of scoring.
171, 174
 On the basis of this premise strict statistical 
analysis of the degree of changes at each time is not as important as histological assessment of the 
type of changes that occur after intra-dermal SLS treatment. This would meet the objective of 
providing observations on skin histopathology following intra-dermal injections of a novel chemical 
with the caveat of not being able to claim strong conclusions based on the results from this small 
study. 
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Table 1: Grading of histopathologic changes in sheep skin following SLS treatment in the sighting 
study. 
 
Histologic changes Grade Description 
Inflammation and 
severity 
0 
1 
2 
3 
No inflammation (0% of tissue affected) 
Minimal (low cellularity, <100 cells per x40 field) 
Moderate (medium cellularity, 100-200 cells per x40 field) 
Marked (high cellularity, >200 cells per x40 field) 
Oedema 
(dilated lymphatics 
with endothelial 
hypertrophy; loosely 
arranged interstitium) 
0 
1 
2 
3 
Absent (0% of tissue affected) 
Minimal vascular changes and interstitial separation 
Moderate vascular changes and interstitial separation 
Marked vascular changes and interstitial separation 
Haemorrhage 
(free red blood cells in 
tissues)  
0 
1 
2 
3 
Absent (0% of tissue affected) 
Mild (0-33%) 
Moderate (33-66%) 
Marked (66-100%) 
Necrosis -  
coagulative 
(intact architecture, 
hypereosinophilia, 
karyorrhexis & 
karyolysis) 
0 
1 
2 
3 
 
Absent (0% of tissue affected) 
Mild (dermis, affecting 0-33% of tissue) 
Moderate (dermis and subcutis, affecting 33-66% of tissue) 
Marked (epidermis, dermis and subcutis, affecting 66-
100% of tissue) 
Fibroplasia 0 
1 
2 
 
3 
Absent (0%) 
Mild (plump and disorganised fibroblast; immature) 
Moderate (mix of parallel and disorganised fibroblast; 
intermediate) 
Marked (parallel spindle cells; mature) 
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3.2. Results 
 
 
3.2.1 Gross changes after intra-dermal treatment of SLS 
 
There was minimal intra-dermal tissue swelling measuring up to 1.5 cm in diameter (score of 1) at 2 
minutes after treatment. Cross-section of tissue biopsies revealed minimal gross changes at that 
time. After 2 hours, treated skin showed marked fluctuant swelling, measuring up to 3 cm in 
diameter (score of 3). A gelatinous and loosely organized appearance was seen in the dermis and 
subcutis on cross-section at that time. From day 1, the surface of treated skin was covered with 
serous and cellular crusting with visual absence of epidermal erosion or ulceration. By day 7 the 
treated skin was more firm, moderately swollen and measured approximately 2 cm in diameter 
(score of 2) with minimal scab formation. Cross-section showed superficial pallor surrounded by 
red-pink border. Tissue swelling of the treated site subsided by day 14, leaving a reasonably firm, 
slightly raised, subcutaneous lesion measuring approximately 1 cm in diameter. At day 21 the 
treated site had a centrally depressed and shrunken area (interpreted as scar) of approximately 0.6 
cm in diameter with an overlying scab, which on day 28 remained attached to the reepithelialised 
tissue beneath. On cross-section the appearance of treated sites from day 21 was of generalized 
tissue pallor, organised architecture and firm texture (interpreted as fibrosis). Changes in the gross 
appearance of un-biopsied treatment site such as discolouration, swelling and scab formation were 
subjectively scored as (0) normal, (1) mild swelling, <1.5 cm diameter; (2) moderate swelling, <2.5 
cm with sero-cellular crusting or scab formation; or (3) severe swelling, >3.0 cm with blanching or 
redness. The mean scores of gross appearance of treated sheep skin over time are summarized in 
Table 2 and presented schematically in Figure 5. 
  
Bleeding from the biopsy wound stopped within 30 minutes after collection, with oozing of plasma 
over the next 24 hours before drying up. The biopsy wounds healed quickly without significant 
complications.  
 
 
3.2.2 Behavioural changes after SLS treatment 
 
None of the three SLS-treated sheep showed clinical signs of pain or discomfort as reflected by 
their normal behaviour and appetite over a 4 day period. Their clinical parameters for heart rate, 
respiratory rate and body temperature were well within the reference ranges of 70–90 beats per 
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minute, 12–20 breaths per minute, and 38.3–39.9°C respectively.175 The mean values and scores of 
respective clinical and behavioural parameters of treated sheep are summarized in Table 3.   
 
Table 2: Mean scores and standard deviations (in brackets) of gross skin appearance at different 
times after SLS treatment of 3 sheep in the sighting study. Gross changes of the treatment sites were 
subjectively scored as (0) normal, (1) mild swelling, <1.5 cm diameter; (2) moderate swelling, <2.5 
cm with redness, crusting or scab formation; or (3) severe swelling, >3.0 cm with blanching or 
redness.  
 
Time Score  Time Score  Time Score 
0 min 0.00 
(0.00) 
 2 hr 2.67 
(0.58) 
 7 day 2.00 
(0.00) 
2 min 1.00 
(0.00) 
 4 hr 2.67 
(0.58) 
 10 day 2.00 
(0.00) 
5 min 1.00 
(0.00) 
 6 hr 3.00 
(0.00) 
 14 day 1.33 
(0.58) 
10 min 1.33 
(0.58) 
 1 day 2.67 
(0.58) 
 21 day 1.00 
(0.00) 
15 min 1.67 
(0.58) 
 2 day 2.33 
(0.58) 
 28 day 1.00 
(0.00) 
30 min 2.00 
(0.00) 
 3 day 2.00 
(0.00) 
   
1 hr 2.00 
(0.00) 
 4 day 2.00 
(0.00) 
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Figure 5: Mean scores and standard deviations of gross skin appearance at different times after SLS 
treatment of 3 sheep in the sighting study. The mean scores and standard deviations of gross 
changes of the treatment sites were based on subjective scores of (0) normal, (1) mild swelling, <1.5 
cm diameter; (2) moderate swelling, <2.5 cm with redness, crusting or scab formation; or (3) severe 
swelling, >3.0 cm with blanching or redness. 
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Table 3: Mean values and standard deviations (in brackets) of clinical and behavioural parameters at 
specific time points after SLS treatment of 3 sheep in the sighting study. 
 
           Time 
 Parameters 
0 min 0.5 hr 4 hr 8 hr 12 hr 1 day 2 day 3 day 4 day 
Rectal temp 
(°C) 
38.57 
(0.06) 
38.57 
(0.12) 
38.87 
(0.23) 
38.93 
(0.21) 
39.03 
(0.15) 
38.97 
(0.06) 
38.77 
(0.25) 
38.70 
(0.26) 
38.70 
(0.20) 
Heart rate 
(per min) 
72.67 
(0.58) 
76.33 
(0.58) 
76.67 
(0.58) 
76.33 
(1.53) 
78.67 
(1.15) 
80.00 
(1.00) 
77.67 
(0.58) 
76.67 
(0.58) 
75.67 
(0.58) 
Respiration 
(per min) 
13.00 
(1.00) 
13.67 
(0.58) 
14.67 
(0.58) 
15.33 
(1.15) 
16.67 
(0.58) 
16.00 
(1.00) 
15.00 
(1.00) 
13.67 
(0.58) 
13.67 
(1.15) 
MM 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
CRT 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
General 
demeanour 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
Posture & 
movement 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
Gait & co-
ordination 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
Appetite - - - 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
 
Scores for clinical and behavioural parameters were taken before and after skin biopsy respectively. 
Behavioural patterns were observed after recovery from sedation, over a 30-minute period. General 
demeanour was scored as (0) bright, alert and responsive, (1) hyperactive/restless, (2) depressed, 
and (3) coma. Movement and posture were scored as (0) normal, (1) biting/rubbing/skin twitching 
of treated sites, (2) arching back, and (3) head drooping. Gait and coordination were scored as (0) 
normal, (1) ataxia, (2) paresis, (3) paralysis. Appetite for food or drink was scored as (0) normal, (1) 
abnormal or (-) not applicable in fasted sheep. Mucous membrane/MM colour was scored as (0) 
pink, (1) pale or (2) otherwise. Capillary refill time/CRT was scored as (0) normal <2 seconds, or 
(1) abnormal >2 seconds. 
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3.2.3. Histological changes at varying times after SLS treatment 
 
Skin biopsies acquired at specific time intervals after SLS treatment, were graded for 
histopathologic changes; the median grades are summarized in Table 4. Histopathology noted at 
different time points following SLS treatment is presented in Figure 6. Skin biopsy samples from 
sheep 3 at 2 minutes and 5 minutes had insufficient deep tissues for analysis, while samples from 
sheep 1 and 3 at 2 hours showed no histopathology in spite of SLS treatment. The latter biopsy 
samples consisted of mature, differentiated structures resembling normal skin in non-treated 
regions, leading to the presumption of failure in capturing the area of pathology. Areas of 
progressive coagulative necrosis of the skin layers at different time points resulted in loss of cellular 
morphology, making grading difficult. Skin samples which were not able to be graded due to 
missed or necrotic areas of interest after treatment were excluded from the grading process. This 
further emphasized the relevance of using the median rather than mean score for histological 
changes in the very small sample size.  
 
At 2 minutes after SLS injection, the deepest hair bulbs were basophilic with an irregular basement 
membrane outline (Figure 6A). Tissue necrosis was accompanied by small multifocal clusters of 
fine granular basophilic material, which was histochemically negative for calcium with the use of 
von Kossa stain.
169, 170
 At 5 minutes after injection, endothelial cells lining the vessels in the deep 
dermis were mildly plump (reactive). At 10 minutes after treatment however, the endothelium of 
blood vessels were more reactive and lymphatic vessels were dilated (interpreted as oedema). Also 
at this time point, vessels, nerves and other soft tissue structures in the deep dermis were affected by 
acute coagulative necrosis which was characterised by hypereosinophilia with loss of cellular 
details and absence of inflammatory infiltrate (Figure 6B). There was minimal associated 
haemorrhage.  
 
From 15 minutes to 2 hours after treatment, the extent of coagulative necrosis progressed from the 
subcutaneous layer to the deep dermis. There was mild intercellular oedema in the epidermis. This 
was accompanied by a mild to moderate increase in numbers of dilated lymph vessels and loosely 
arranged collagen bundles in the superficial and deep dermis (interpreted as oedema). There was 
also a mild increase in the numbers of peri-vascular mast cells within the superficial dermis.  
 
Moderate numbers of neutrophils infiltrated adjacent to necrotic areas in the superficial and deep 
dermis by 4 hours after SLS injection; their numbers increased by 6 hours and reached marked 
numbers (>10 cells per x 100 field) at day 1 after treatment. By 4 hours, there were detectable 
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thromboses which were characterized by vascular occlusion by eosinophilic fibrillar material, and 
fibrinoid necrosis of vessels in the dermis. Necrosis progressed to the superficial dermis while the 
epidermis had increased numbers of apoptotic keratinocytes but otherwise showed minimal 
necrosis. 
 
By day 1 after SLS treatment, there was epidermal necrosis with moderate hyperplasia and 
thickening of adjacent epidermis with minimal intracellular and intercellular oedema, characterized 
by cytoplasmic swelling (ballooning degeneration) and prominent intercellular desmosomes 
(spongiosis). There were moderate numbers of neutrophils (5-10 cells per x 100 field) adjacent to 
necrotic areas within the epidermis and subjacent superficial dermis. The latter was accompanied 
with a minimal amount of haemorrhage. Full thickness coagulative necrosis eventually developed in 
all layers of the skin. However the subcutis and deep dermis were affected by necrosis much earlier 
(at 10 minutes) than the superficial dermis and epidermis.  
 
By day 2 after the treatment, there was full thickness coagulative necrosis of the skin tissue with no 
discernible cellular morphology. Although moderate numbers of necrotic neutrophils were present 
within the thickened epidermis, deep dermis and subcutis, an even greater number was found within 
the superficial dermis. Full thickness coagulative necrosis of the skin persisted up to day 7 after 
treatment. At this time small numbers of immature, plump and disorganized fibroblasts began to 
proliferate within the dermis amidst an immature, highly cellular stroma of short, thin or amorphous 
collagen fibres admixed with ground substance. 
 
At day 7, reepithelialisation began at the periphery before migrating under the extensive layer of 
necrotic scab (eschar). By day 10 the regenerating epidermis was moderately hyperplastic, at more 
than twice the normal epidermal thickness. From days 10 to 14, the deep dermis and subcutis 
contained moderate angiogenesis, multifocal areas of haemorrhage and minimal amounts of 
histiocytic infiltrates; fibroplasia and development of early granulation tissue was characterized by 
proliferation of disorganized and parallel fibroblasts of intermediate maturity, and formation of 
parallel vessels perpendicular to the tissue surface. Active fibroplasia continued at 21 and 28 days 
after treatment with progressive maturation of fibrous scar tissue within the deep dermis and 
subcutis. There was progressive collagen deposition within the stroma, from short, thin fibres of 
high cellularity to thick, parallel or whorled fibres of low cellularity. 
  
Complete reepithelialisation with full coverage of the wound occurred by day 21. Epidermal 
hyperplasia had resolved, to a degree on day 28, and was under twice the normal epidermal 
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thickness. The dermis had very few adnexal structures most of which were replaced by abundant 
fibrous stroma of low vascularity, and minimal to moderate numbers of multinucleated giant cells, 
macrophages, lymphocytes and plasma cells. Small numbers of macrophages containing brown 
intra-cytoplasmic pigment (interpreted as haemosiderophages) were detected within the subcutis, 
indicating previous haemorrhage. Extending downwards from the superficial dermis into the 
subcutis, the resulting scar formation was characterized by a reduction in adnexal structures and 
replacement by dense fibrous tissue which was progressively more mature and organized into 
parallel spindle cells. 
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Figure 6: Histopathology at different times after SLS treatment. Sheep skin; H & E stained sections. 
A. Deep hair bulbs were basophilic with irregular basement membrane (1) and collagenous 
necrosis characterised by hypereosinophilia with loss of cellular details (2) at 2 minutes. Bar = 
502 µm; magnification = 400x.   
B. A higher magnification showing necrosis of nerves (1), vessel (2) and collagen (3) at 2 minutes. 
Bar = 514 µm; magnification = 1000x 
C. Fibroplasia and angiogenesis in the deep dermis at day 7. Bar = 498µm; magnification = 200x. 
D. Dermal fibrosis lacking adnexal structures, with complete reepithelialisation (1) subjacent to 
the necrotic eschar (2) at day 28. Bar = 498µm; magnification = 200x. 
514 µm 498 µm 
502 µm 502 µm 
A 
B 
C 
 
D 
1 
2 
1 
2 
3 
1 
2 
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Table 4: Median grades of skin histopathologic changes at specific time points after SLS treatment 
of 3 sheep in the sighting study. 
 
 
 
Time   
Epidermis Superficial dermis Deep dermis Subcutis  
H O N I S H O N I F H O N I F H O N I F 
0 min 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
2 min 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 
5 min 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 1 1 0 0 
10 min 0 0 0 0 0 0 0 0 1 0 0 1 2 0 0 0 1 2 0 - 
15 min 0 0 0 0 0 0 0 0 1 0 0 1 2 0 0 - 1 3 0 - 
30 min 0 0 0 0 0 0 0 0 1 0 0 1 3 0 0 - 1 3 0 - 
1 hr 0 0 0 0 0 0 0 0 1 0 0 2 3 0 0 - 1 3 0 - 
2 hr 0 0 0 0 0 0 0 0 1 0 0 3 3 0 0 - 1 3 0 - 
4 hr 0 0 0 0 0 0 1 1 1 0 - 2 3 1 - - 2 3 2 - 
6 hr 0 0 0 0 0 1 1 1 2 0 - 2 3 1 - - 2 3 2 - 
1 day 0 2 3 2 1 1 2 3 3 0 - - 3 3 - - 3 3 3 - 
2 day - - 3 - 1 1 - 3 3 - - - 3 2 - - - 3 - - 
3 day - - 3 - 0 - - 3 - - - - 3 - - - - 3 - 1 
4 day - - 3 - 0 - - 3 - - - - 3 - - - - 3 - 1 
7 day - - 3 - 0 - - 3 - - - - 3 - 1 - - 2 - 2 
10 day - - 3 - 0 - - 3 - 1 - - 3 - 1 0 - 2 1 2 
14 day - - 0 0 0 - - 0 2 1 1 - 0 1 2 1 - 0 1 2 
21 day 0 0 0 0 0 0 0 0 1 2 1 0 0 1 2 1 0 0 1 2 
28 day 0 0 0 0 0 0 0 0 1 2 1 0 0 2 3 1 0 0 1 3 
 
Skin treated with SLS were excised, processed and stained with H & E. Histopathologic changes 
(S= slough, N = necrosis, I = inflammation, O = oedema, H = haemorrhage, F= fibrosis) within 
different skin layers were scored with a 4-point grading system: 0 = normal (0% change), 1 = mild 
(>0-33% change), 2 = moderate (>33-66% change), 3 = severe (>66-100% change). Medians were 
calculated from n = 3 individual sheep skin specimens. Complete coagulative necrosis preserved 
tissue architecture but not cellular morphology in the skin, making grading difficult and therefore 
not applicable (-).
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3.3. Discussion 
 
An effective chemical alternative to surgical mulesing should ideally be painless by causing rapid 
necrosis of the nerves responsible for pain sensation followed by uncomplicated healing with scar 
tissue replacing adnexal units, resulting in stretching and modification of the breech to minimize 
blowfly strike. 
 
The time for wound healing with complete reepithelialisation after intra-dermal SLS treatment of 
the flank took approximately 21 days which was in agreement with previous reports of wound 
repair occurring between 2 and 4 weeks after topical treatment of the breech with a patented caustic 
chemical.
57, 176
 Although healing times for mulesing have been described to occur from up to 21 
days
177
 to up to 47 days,
63
 these were not directly comparable to SLS treatment owing to the 
different areas of skin being treated and the much larger wound for mulesing. Resolution of SLS 
induced skin necrosis involved sequential and overlapping processes of inflammation, proliferation 
and remodelling. This resulted in reepithelialised skin with a dermis consisting of fibrous scar tissue 
which lack adnexal structures, making it worthwhile to pursue further investigations of intra-dermal 
SLS treatment as an alternative to mulesing.  
 
One of the purposes of the sighting study was to refine the frequency of sampling time points for 
optimum characterization of wound healing. Coagulative necrosis occurred as early as 2 minutes 
after SLS treatment and was featured prominently within the subcutis before progressive 
involvement of the dermis and epidermis. The presence of basophilic deep hair bulbs with irregular 
basement membrane outline and small multifocal clusters of fine granular material within necrotic 
tissues could infer the possibility of SLS precipitation; SLS concentration of 0.1% or greater has 
been shown to precipitate non-specifically with serum proteins and lipoproteins in agar diffusion 
and immunoeletrophoresis.
178
 This possibility can be confirmed by further trials using larger sample 
sizes in the treatment and control groups. Tissue proliferation began in the subcutis from day 3  
followed by epithelial regeneration accompanied with active fibroplasia and angiogenesis from day 
7 and culminated in organization and maturation of scar tissue (remodelling) by day 28.  Based on 
these critical time points for histopathologic changes in the skin, biopsy frequency was reduced to 
exclude sampling from days 4 and 10 in the main study. Days 4 and 10 were merely extensions 
from the tissue proliferation stage and did not offer any additional changes or further development 
in the wound healing process that would not be captured by the prior and subsequent collection time 
points. 
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The dermis was the target site for SLS injection in terms of inducing necrosis of adnexal units and 
nerve plexus, thus removing the vital structures required for a less painful depilatory effect which is 
equivalent to mulesing. The early and extensive necrosis of the subcutis at 2 to 15 minutes after 
treatment suggested that the 4 SLS injections could have been administered too deep and close 
together in the subcutaneous layer rather than within the dermis of the treatment area. The 
inconsistency of SLS administration was prevented by the replacement of needle injections with a 
needleless system for pressurized intra-dermal administration of SLS in the main study.  
 
The needleless SkinTraction® applicator has a nozzle head consisting of 4 tubes arranged in a grid 
and separated at a distance of 10 mm to provide pressurized delivery of uniform and evenly 
distributed doses into the skin. This would counter the histopathologic affects of extensive 
subcutaneous necrosis from concentrated SLS distribution associated with manual injections and 
theoretically provide more rapid wound healing. Extensive subcutaneous necrosis was hypothesized 
to have caused the formation of an adherent eschar which resulted in delayed reepithelialisation; 
large areas of necrosis will take longer to resolve, slowing wound healing and subsequent 
sloughing. The extent of delay can be appreciated when compared to a study of uncomplicated 
wound healing following 6-mm punch biopsy in sheep skin described complete reepithelialisation 
in 5-7days.
179
  
 
The local anaesthetic, Lignocaine has a rapid onset of 2 minutes and can last for up to 2 hours after 
administration.
180
 Studies on the effects of intra-dermal or subcutaneous injections of lignocaine on 
the microvasculature demonstrated that the vasoactivity of capillary vessels was affected by 
different concentrations of the local anaesthetic in human skin.
181-184
 A concentration of 2% 
(20mg/ml) produced vasodilation in comparison with the vasoconstriction at concentrations of 0.5% 
(5mg/ml) and 1% (10mg/ml). In addition, the administration of 2% Lignocaine contributed to the 
increase in cutaneous blood flow which was associated with the trauma of needle stick injury.
183
 
Injections of 2% Lignocaine were applied prior to the biopsy of SLS treated skin in this study and 
could contribute to the early increase in capillary blood flow which enhanced the influx of pro-
inflammatory vasoactive mediators and chemotactic factors. This could result in the early 
accentuation of oedema and inflammatory response associated with SLS treatment. 
 
The administration of long-acting antibiotic on day 4 after treatment could positively influence the 
healing process by preventing potential infection of the wound.
64
  Although preventive antibiotics 
were beneficial in terms of minimizing complications and allowing optimal conditions for 
assessment of the healing process in the skin after SLS treatment, this would not be practical in field 
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situations. This is another reason why the results of this study are not directly comparable to 
mulesing. 
 
Treated sheep displayed normal behaviour and appetite patterns during their periods of observation 
over the initial four days, which therefore inferred negligible pain or discomfort after SLS 
treatment. Their heart and respiratory rates were at the upper end of the reference ranges which 
could reflect their young age or stress during handling. The treatment was well tolerated by sheep as 
a result of SLS causing rapid and deep necrosis of all cutaneous structures. Sensory nerve fibres 
were difficult to assess due to their unreliable presence in the section and delicate nature that is 
easily masked by the changes of necrosis, both in H & E and special stained section,
133
 nevertheless 
rarely noted nerves were similarly affected by the indiscriminate and widespread necrotic change as 
shown in Figure 6B.  
 
 
3.3.1. Limitations of experimental protocols in the sighting study 
 
Histopathologic findings in the skin after SLS administration were centred on coagulative necrosis 
followed by overlapping stages of inflammation, proliferation and remodelling. Although 
histopathologic assessment in the sighting study included grading parameters of epidermal 
sloughing, inflammation, haemorrhage, oedema, necrosis and fibrosis, the wound healing process 
was complex and covered other parameters which were equally as important as those which were 
graded. For a more complete assessment of wound healing, grading of histopathologic parameters 
in the wound bed were expanded to include fibrin, angiogenesis, collagen, and reepithelialisation in 
the main study. Expanding the lesion parameters would improve the sensitivity of detecting specific 
sequential histopathologic change and enhance repeatability.
171
 Histopathologic grading was 
summarized in its application to two broad sections of the skin, the superficial layers (epidermis and 
superficial dermis) and deep layers (deep dermis and subcutis); this simplified the grading process 
while still providing an adequate assessment of the progress of wound healing. 
 
Punch biopsy can potentially cause disadvantages of obtaining inadequate material and exclusion of 
deeper tissue.
162
 Skin biopsy samples from sheep 3 at 2 minutes and 5 minutes had insufficient deep 
tissues while samples from sheep 1 and 3 at 2 hours after SLS treatment showed no histopathology; 
these were therefore not able to be graded for histopathologic changes. The finding of little or no 
histopathology in some of the treated skin could be the result of the biopsy missing the lesion while 
insufficient tissue samples could reflect a failure in correct biopsy technique. The thickness and 
62 
 
mobility of the flank skin made it difficult to maintain a consistent biopsy process despite the 
placement of markers on treated sites. In addition, the method of manual restraint of sedated sheep 
by a second person could affect tension of skin folds and alter the position of marked skin over the 
treatment sites, resulting in a biopsy sample which showed little or no histopathology. In order to 
minimize samples with missing areas of interest in the main study, care was exercised in obtaining 
skin biopsy in a proper manner from a desensitized and sedated sheep, positioned in lateral 
recumbency. The protocol describing the biopsy procedure will be elaborated on in the methods 
chapter of the main study. 
 
All three of the treated sheep were assessed at a safe distance, for clinical signs of pain or 
discomfort via their behaviour and appetite patterns. Limited financial resources prevented the use 
of video surveillance to accurately record changes in behaviour and appetite which truly reflect 
pain,
185
 in the absence of disturbance associated with the ‘human (or predator)-induced’ analgesia 
phenomenon. Sheep were instead observed simultaneously with their untreated cohorts over a 30 
minute period every 4 hours on the first day, then daily for four days. Buprenorphine can provide 
pre-emptive analgesia for up to 12 hours
186
 and therefore it is likely that any pain associated with 
the treatment would have been masked to a degree and the results therefore are not directly 
comparable to the behavioural indicators of pain from mulesing studies. The use of narcotic 
analgesia in this study however was necessary for animal ethics considerations. Extensive 
additional studies involving field trials on the breech would have to be done before we can claim 
that there is no pain associated with SLS treatment. 
 
Previous studies on pain assessment in sheep have used one of the three approaches: (a) measures of 
general body function (e.g. feed or water intake/preference or weight gain), (b) measures of 
physiological responses (e.g. plasma cortisol concentrations) and (c) measures of behavioural 
changes (e.g. mobility or socialization). All three approaches are valid and reliable methods for the 
evaluation of pain in practical settings.
187, 188
 Attempts would be made in the main study to observe 
sheep in an obscured position from a safe distance away to further minimize the threat of human 
presence. The inclusion of additional parameters such as body weight gain to assess pain in the 
present study was considered to be of value as behavioural indicators and appetite (food or water 
preference) alone did not seem to be providing sufficient sensitivity. Measures of general body 
function such as weight gain are simple and inexpensive to perform, however they do not reflect the 
current status of the animal but rather the status over the interval between observations.
188
 
Measurements of body weight before and after the treatment phase were planned for sheep entering 
the main study.  
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The current status of pain in sheep can be assessed by measures of physiological responses or 
behavioural changes.
187
 Physiological assessment of pain through plasma markers of 
inflammation
189
 such as acute phase proteins (haptoglobin, serum amyloid A and fibrinogen) which 
are released during the acute phase response as part of a systemic reaction, have been useful 
indicators of acute pain in sheep.
190-193
 Cortisol hormone released by the hypothalamic-pituitary-
adrenocortical system in response to tissue damage, similarly enables assessment of acute pain.
194, 
195
 Ideally observations for both behavioural and physiological change in affected animals would 
increase the sensitivity and specificity of pain assessment.
189
 Physiological responses were not 
measured in this study due to financial and time constraints; though this was partially compensated 
for by including measures of production changes such as appetite and body weight gain with 
behavioural observations to improve the overall assessment of pain in treated sheep. Measurement 
of several parameters will likely give an adequate account of the complex response to pain in 
treated sheep. 
 
 
3.4. Conclusion 
 
Based on the results of this sighting study, intra-dermal SLS treatment is considered a mulesing 
alternative worthy of further investigation. The coagulative necrosis of subcutaneous tissue as early 
as 2 minutes after treatment effectively destroyed all structures of the skin including the adnexa, 
vasculature, neural network and collagenous structures. The compromised vascular supply caused 
subsequent necrosis of the superficial dermis and epidermis. The presumed destruction of the 
cutaneous nerve plexus which supply sensory fibres has resulted in the absence of pain sensation as 
reflected in the normal behaviours and appetite of treated sheep. 
 
Several modifications of the sighting study protocol will be made for the main study. Extensive 
subcutaneous necrosis attributed to deep and concentrated manual injections would be corrected for 
by the use of a patented applicator (SkinTraction®) to ensure consistency in administration of intra-
dermal SLS in all 6 sheep. Modifications in histopathologic assessment were planned for the main 
study to include a wider range of parameters which would provide a sufficient overview of the 
wound healing process.   
  
The main study would focus on specific collection times of skin samples after treatment for 
histological and ultrastructural examination in order to assess the mechanism of action of SLS and 
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the healing process. Biopsy frequency in the main study would be conducted at similar time 
intervals, however with the exclusion of days 4 and 10, over the 28-day period. Problematic skin 
biopsy samples which were inadequate or missing treatment areas would be difficult to prevent but 
could be minimized by taking care during restraint of sheep and biopsy of the marked treatment 
sites.     
 
In addition to measures of general body function (appetite) and behavioural changes, measurements 
of body weight gain over the trial period would also be included in the main study.  Measurement of 
several parameters will likely give an adequate account of the complex response to pain and enable 
correlations to be made on whether SLS treatment produced pain or discomfort in the sheep 
involved. 
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4. Main Study 
 
Cutaneous SLS injections deployed in the sighting study produced full thickness necrosis which 
affected all structural elements and soft tissue components of sheep skin. The destruction of nervous 
and adnexal structures resulted in a less painful, depilated scar formation which would potentially 
cause breech modification (on application). Intra-dermal SLS as a chemical alternative to mulesing 
is potentially a suitable candidate worthy of further investigation.    
 
The main study was designed to further evaluate the effects of cutaneous SLS based on established 
working parameters and protocol modifications from the sighting study. Modifications were 
primarily aimed at improving SLS dermal delivery through a needleless intra-dermal applicator and 
reducing biopsy frequency with concentration of collection around time points of maximum 
interest. The protocol was also adjusted to decrease the risk of the biopsy missing the injection site, 
parameters used for histopathologic assessment were refined and measurement of body weight gain 
to enhance the assessment of pain was incorporated. 
 
In addition transmission electron microscopy would be conducted to study the mode of action of 
SLS on skin components at the ultrastructural level during the initial treatment phase. Six sheep 
entered a main study conducted over a period of 7 weeks to assess the underlying healing process 
and outcome of pressurized, needleless application of SLS into skin sites on the flank.   
 
66 
 
4.1. Methods and materials 
 
 
4.1.1. SLS treatment and skin biopsy 
 
Six plain bodied Merino sheep wethers (neutered males) of approximately 9 months of age, sourced 
from the same supplier were used for the main study. Previous studies using similar methodology 
with other chemicals and modes of treatment have shown that 6 replicates of each treatment time 
were optimal to allow for any changes that may result due to individual animal variation rather than 
the parameter being studied.
57
 
 
A week before the trial, sheep for the main study were housed in groups of 3 (2 sheep with one 
untreated cohort), on wire floor and under cover, and they were retained in this housing for the 
duration of the study. They were fed 250 g of calf pellets per head twice a day, supplemented with 
ad libitum lucerne chaff, and had free access to water. The sheep were weighed and physically 
examined to confirm a healthy status. 
 
As in the sighting study, the treatment sites were located at similar flank locations (see section 3.1). 
The sheep were prepared for treatment using similar materials and methods (see section 3.1.2), 
except the applicator (SkinTraction®), instead of a needle and syringe, was used for needleless 
intra-dermal treatment with SLS. Patented research conducted by Cobbett Technologies for the 
AWI has established optimal SLS concentration and treatment using the pressurised, needleless 
applicator  to provide effective results.
157, 158
 This needleless applicator delivered small pressurized 
doses of  SLS solution (7% weight/volume) containing benzyl alcohol (20 mg/ml), phosphate buffer 
and water for injection (formulated by Cobbett Technologies Pty Ltd).
156
 The applicator device has 
a regulator which sends optical signals to a controller to determine the final dosage pattern and flow 
of SLS during intra-dermal administration.
158
 The operator (Peter Welch) ensured that the delivery 
tubes of the nozzle head were evenly loaded against the skin surface to provide uniform intra-
dermal deposition of SLS (Figure 7). In this instance, the uniform pressure of delivery tubes against 
the skin resulted in the skin being pre-tensioned and firing of the trigger held applicator. 
 
The needleless applicator, SkinTraction® operates under a pressure of 35 pounds per square inch 
(psi) (241 kilopascals (kPa)) and has a nozzle head (Figure 8) which consists of a grid of 4 delivery 
tubes measuring 0.24 mm in diameter and spaced at 10 mm from each other to provide a total 
treated area of 4 cm
2
. The automatic injection process ensures each of the 4 tubes accurately 
67 
 
delivers 0.2 ml of 7% SLS into the dermis, which minimises human error. For a total treated area of 
4 cm
2
, the total amount injected was 0.8ml x 70mg/ml = 56mg. Therefore the dosage per treatment 
area was 56mg/4 cm
2
 = 14mg/cm
2
 which was equivalent to the dose administered in the sighting 
study. 
  
 
 
 
 
 
 
 
 
Figure 7: Diagrammatic representation of how the delivery tubes of the nozzle head attached to the 
applicator, were evenly loaded against the skin surface to ensure uniform intra-dermal deposition of 
SLS; adapted from Welch, 2010.
159
 
 
 
 
Figure 8: The nozzle head of the needleless applicator, SkinTraction® (measuring 50 mm in entire 
length and 22 mm in base diameter) consists of 4 delivery tubes, arranged in a grid and separated at 
a distance of 10 mm.   
 
After the intra-dermal administration of SLS, serial punch biopsies (8mm diameter) of the 
anesthetized skin were taken from each treated area at 2, 5, 10, 15, 30 minutes; 1, 2, 4, 6 hour and 1, 
2, 3, 7, 14, 21, 28 days. Biopsy frequency in this study was less than the sighting study as it 
excluded sampling at days 4 and 10 which were considered redundant. Changes in the gross 
appearance of the un-biopsied treatment site such as discolouration, swelling, crusting and scab 
formation were scored subjectively based on criteria established in the sighting study (see 3.1.3). In 
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order to minimise the sampling of sites adjacent to and not including the treated area, a problem 
identified in the sighting study, the biopsy was taken with care from sheep which were sedated, skin 
desensitised by inverted L-block and positioned in lateral recumbency rather than sampling from 
manually restrained sheep. The biopsy was performed carefully by holding the punch with three 
fingers; while the thumb and the middle finger supported and rotated the punch, the index finger 
stabilized and exerted pressure on the punch. The punch was pushed downwards by rotating 
movements until a reduction in resistance was felt to indicate entry into subcutaneous tissue. 
 
Skin biopsy specimens were handled gently with Adson’s toothless forceps, halved and fixed 
separately in formalin and gluteraldehyde for histological assessment under light and electron 
microscope respectively. After biopsy, each site was topically treated with an antibacterial fly 
repellent (Extinosad aerosol, ELANCO Animal Health, West Ryde, NSW). Suturing after biopsy 
was not performed due to the small size of the wound which healed quickly. An intramuscular 
injection of a long acting antibiotic (5mg/kg Oxytetracycline, Engemycin-100, Intervet, Bendigo 
East, VIC) was given on day 4 after treatment to minimize potential wound infection which can 
delay and complicate the healing process. 
 
 
4.1.2. Assessment of SLS-treated sheep 
 
The 6 treated sheep were kept in groups of 3 along with an untreated cohort which served as a 
negative control. Observations of clinical and behavioural parameters were similar to those 
employed in the sighting study (refer to section 3.1.3). In addition to the sighting study 
measurements, records of body weight were obtained at the beginning and end of the 28-day trial 
period.  
 
 
4.1.3. Preparation of skin biopsy specimens for light microscopy  
 
Half of each skin biopsy specimen was fixed in 10% neutral buffered formalin and H & E - stained 
sections were prepared by a standard protocol which was identical to that used in the sighting study. 
Similarly, slides with sections of tissue necrosis associated with multifocal clusters of fine granular 
basophilic material were stained with the von Kossa staining method (refer to section 3.1.4).  
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4.1.4. Preparation of skin biopsy specimens for electron microscopy  
 
The second half of each skin biopsy was fixed in 3% gluteraldehyde in 0.1M cacodylate buffer. To 
enhance tissue fixation all skin specimens were subsequently sectioned into tiny pieces 
(approximately 1x1x1mm) under a dissecting microscope using a scalpel blade and processed 
categorically according to their site of origin. Fixed tissue pieces from the dermis were processed 
using a microwave (PELCO BioWave) protocol.196, 197  Firstly the specimens were rinsed with 
0.1M cacodylate buffer followed by a water rinse. The specimens were then subjected to a series of 
increasing concentrations (50%, 60%, 70%, 80%, 90% and 100%) of acetone for dehydration. They 
were subsequently infiltrated with a series of increasing concentrations (25%, 50%, 75% and 100%) 
of EPON resin. Resins containing the embedded dermal tissues were allowed to polymerise 
overnight in a warm (40C) convection oven.  
 
Resin embedded tissues were initially sectioned into 500 nm thickness, placed on glass slides and 
stained with Toluidine blue before viewing under light microscope to select relevant areas for 
ultrathin sections. Selected areas of resin embedded tissues were then sectioned into 60-80 nm 
thickness by an ultra-microtome and placed onto a copper grid (200 mesh squares). Tissues on the 
grid were stained with uranyl acetate (5% in 50% ethanol) and lead citrate for 2 minutes and 1 
minute respectively. Tissue sections were examined under a transmission electron microscope 
(JEOL 1010) at 80kV. Images of interest were captured by a digital camera. As early 
histopathologic changes were noted in the deep dermis and subcutis of the skin, areas of the deep 
dermal and subcutaneous tissue were the main focus for electron microscopy. Damage to specific 
tissue structures immediately after SLS treatment were compared with their normal counterparts 
from untreated (control) tissues in order to analyse the ultrastructural changes which occurred.  
 
 
4.1.5. Histopathologic assessment of skin biopsy specimens 
 
The grading of histopathologic changes in skin specimens over time after SLS treatment was similar 
to that used for the sighting study (see section 3.1.4). However several modifications were made to 
expand on the results of the sighting study. Histopathologic grading was applied to two broad 
sections of the skin, the superficial layers and deep layers; this simplified the grading process while 
still providing an adequate assessment of the progress of wound healing in the six sheep. The 
superficial skin layer consists of epidermis, upper hair follicles and sebaceous glands, and the deep 
skin layer contains lower hair follicles and apocrine glands and subcutis. A 4 point grading system 
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was used to score histopathologic changes subjectively within 10 areas of the wound bed under 
light microscopy:  
a) Grade 0, no change  
b) Grade 1, mild change 
c) Grade 2, moderate change 
d) Grade 3, severe change.  
 
Grading of histopathologic parameters in the wound bed was expanded to include fibrin, 
angiogenesis, collagen, and reepithelialisation in addition to haemorrhage, inflammation, oedema, 
necrosis and fibrosis. The grading criteria for each lesion parameter are described in Table 5. 
Expanding the lesion parameters to include fibrin, angiogenesis, collagen and reepithelialisation 
would improve the sensitivity of detecting specific sequential histopathologic change during wound 
healing and enhance repeatability.
171
 Fibrin occurs as a result of necrosis or damage to the vascular 
endothelium. Angiogenesis and reepithelialisation are vital processes of tissue proliferation and 
early wound healing.
138
 Collagen is essential in remodelling as it forms the bulk of scar tissue 
during the wound healing process. Its orderly formation of fibrils provides the characteristic 
birefringence under polarized light.
198
  
 
Birefringent collagen fibres (Type I and III) have been used in histophotometric analysis of wound 
healing in rat skin.
199
 Activated fibroblasts in granulation tissue become bipolar and secrete 
components of the extracellular matrix such as fibronectin, proteoglycan and types I and III 
collagen fibres.
134, 140, 141
 Collagen synthesis is initiated hours after injury and is prominent after a 
week and can continue for up to 18 months.
198, 200
 For the histophotometric analysis of wound 
healing in rat skin, Rebolla et al (2013) distinguished the number and type of collagen fibres under 
polarised light microscopy where the predominance of thin (type III) and thick (type I) collagen 
fibres occurred consecutively in the early and late phase of the tissue repair process.
199
 Qualitative 
assessment for the presence of birefringent collagen fibres was applied as part of the grading 
process of the skin biopsy samples obtained after SLS treatment in the main study. 
 
As with the sighting study, blind and randomized grading followed by histopathologic assessment 
of skin specimens were performed. Once the H & E - stained sections were graded and their origins 
revealed, calculations were made on the mean scores of each histopathologic change from 10 fields 
per sheep, and the median of the histopathologic grades for all six sheep were summarized 
schematically. The small sample size of 6 was not large enough to test various statistical 
assumptions. Emphasis was therefore placed on the morphologic interpretation of lesions (or 
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descriptive results) rather than the statistical inference (e.g. P-values) of scoring. The median was 
applied because of the small sample size and accommodated for factors which lead to variation in 
scoring (e.g. missed tissue on sampling); it showed the midpoint value and limited outliers or 
extreme scores.
172, 173
 However unlike the sighting study, scoring in the main study was completed 
without complications by extensive necrosis and thus allowed calculation of mean and standard 
deviation with the purpose of showing how much variation existed from the averaged scores of 
histopathologic changes in the treated skins from the 6 sheep.  
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Table 5: Grading of histopathologic changes in sheep skin following SLS treatment in the main study. 
 
Histologic changes Grade Description 
Inflammation and 
severity 
0 
1 
2 
3 
No inflammation (0% of tissue affected) 
Minimal (low cellularity, <100 cells per x40 field) 
Moderate (medium cellularity, 100-200 cells per x40 field) 
Marked (high cellularity, >200 cells per x40 field) 
Oedema 
(dilated lymphatics 
with endothelial 
hypertrophy; loosely 
spaced interstitium) 
0 
1 
2 
3 
Absent (0% of tissue affected) 
Minimal vascular changes and interstitial separation 
Moderate vascular changes and interstitial separation 
Marked vascular changes and interstitial separation 
Fibrin 0 
1 
2 
3 
Absent (0% of tissue affected) 
Minimal (0-33%) 
Moderate (33-66%) 
Marked (66-100%) 
Haemorrhage 
(free red blood cells 
in tissues)  
0 
1 
2 
3 
Absent (0% of tissue affected) 
Mild (0-33%) 
Moderate (33-66%) 
Marked (66-100%) 
Necrosis  
(intact architecture, 
hypereosinophilia, 
karyorrhexis and 
karyolysis) 
0 
1 
2 
3 
Absent (0% of tissue affected) 
Mild (dermis, 0-33% of tissue affected) 
Moderate (dermis and subcutis, 33-66% of tissue affected) 
Marked (epidermis, dermis and subcutis, 66-100% of tissue 
affected) 
Fibroplasia 0 
1 
2 
3 
Absent (0%) 
Mild (plump and disorganised fibroblast; immature) 
Moderate (mix of parallel and disorganised fibroblast; intermediate) 
Marked (parallel spindle cells; mature) 
Angiogenesis 0 
1 
2 
 
3 
Absent (0%) 
Small and random blood vessels (>5-10 vessels per x40 field) 
Mix of perpendicular and random blood vessels (5-10 vessels per 
x40 field) 
Large perpendicular vessels (<2-5 vessels per x40 field)  
Collagen 
(birefringent fibres 
appear bright against 
a dark background 
under polarised light 
microscopy) 
0 
1 
 
2 
 
3 
 
Absent (0%; necrotic collagen fibres are non-birefringent) 
Mild (thin, short or amorphous fibres admixed with ground 
substance, high cellularity; 0-33% birefringent) 
Moderate (mix of thin and thick fibres, moderate cellularity; 33-
66% birefringent) 
Marked (thick, parallel or whorled fibres, low cellularity; 66-100% 
birefringent) 
Reepithelialisation  
 
0 
1 
2 
3 
Absent (0%) 
Minimal hyperplasia (<2x normal thickness; 66-100% coverage) 
Moderate hyperplasia (>2x normal thickness; 33-66% coverage) 
Marked hyperplasia (>3x normal thickness; <33% coverage) 
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4.2. Results 
 
 
4.2.1. Gross changes after intra-dermal treatment of SLS  
 
At 2 minutes after treatment, there was minimal intra-dermal tissue swelling which measured 
approximately 1 cm in diameter; cross-sectional biopsy showed minimal gross changes. After 4 
hours there was marked fluctuant swelling of treated skin which measured approximately 3 cm in 
diameter; cross-sectional biopsy revealed a gelatinous and loosely organized gross appearance of 
the dermis and subcutis. At day 2 the surface of the treated skin was covered with sero-cellular 
exudation and crusting which obscured the underlying epidermis for detectable erosion or 
ulceration. At day 7 after treatment the skin was slightly firm with moderate swelling measuring 
approximately 2 cm in diameter; cross-sectional biopsy showed superficial pallor (interpreted as 
necrosis) surrounded by red-pink border (interpreted as angiogenesis). At day 14 the treated skin 
was reasonably firm, slightly raised and measured approximately 1.5 cm in diameter. At day 21 the 
treated area was centrally depressed and shrunken, measuring approximately 0.8 cm in diameter 
with an overlying scab which was starting to lift off by day 28, leaving reepithelialised and 
depilated tissue which appeared grossly as firm and pale with organised architecture (interpreted as 
fibrous scar tissue) on cross-section. The mean scores of gross appearance of treated sheep skin 
over time are summarised in Table 6 and presented schematically in Figure 9. Gross changes of the 
treatment sites were subjectively scored as (0) normal, (1) mild swelling, <1.5 cm diameter; (2) 
moderate swelling, <2.5 cm with redness, crusting or scab formation; or (3) severe swelling, >3.0 
cm with blanching or redness. 
 
 
4.2.2. Behavioural changes after SLS treatment  
 
The SLS-treated sheep showed minimal clinical signs of pain or discomfort as reflected by their 
relatively undisturbed behaviour and normal appetite over a 4 day period when compared with their 
untreated cohort (negative control). Half of the treated sheep showed signs of restlessness 
(increased pacing and getting up and down) and biting and/or twitching of flank skin on days 1 and 
2. Their clinical parameters for heart rate, respiratory rate and body temperature were well within 
the reference ranges of 70–90 beats per minute, 12–20 breaths per minute, and 38.3–39.9°C 
respectively.
175
 The mean values and scores of respective clinical and behavioural parameters of 
treated sheep are summarized in Table 7.  The 6 treated sheep had an average body weight gain of 
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2.85 kg (standard deviation = 0.19) over the 28-day trial period in comparison with an average body 
weight gain of 2.93 kg (standard deviation = 0.21) in the 3 untreated sheep. 
 
Table 6: Mean scores and standard deviations (in bracket) of gross skin appearance at different 
times after SLS treatment of 6 sheep in the main study. Gross changes of the treatment sites were 
subjectively scored as (0) normal, (1) mild swelling, <1.5 cm diameter; (2) moderate swelling, <2.5 
cm with redness, crusting or scab formation; or (3) severe swelling, >3.0 cm with blanching or 
redness. 
 
Time Score  Time Score  Time Score 
0 min 0.00 
(0.00) 
 1 hr 1.67 
(0.52) 
 3 day 2.17 
 (0.75) 
2 min 1.00 
(0.00) 
 2 hr 2.17 
(0.41) 
 7 day 1.67 
(0.52) 
5 min 1.00 
(0.00) 
 4 hr 2.50 
(0.55) 
 14 day 1.50 
(0.55) 
10 min 1.00 
(0.00) 
 6 hr 2.67 
(0.52) 
 21 day 1.33 
(0.52) 
15 min 1.17 
(0.41) 
 1 day 2.67 
(0.52) 
 28 day 1.00 
(0.00) 
30 min 1.50 
(0.55) 
 2 day 2.33 
(0.52) 
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Figure 9: Mean scores and standard deviations of gross skin appearance at different times after SLS 
treatment of 6 sheep in the main study. The mean scores and standard deviations of gross changes 
of the treatment sites were based on subjective scores of (0) normal, (1) mild swelling, <1.5 cm 
diameter; (2) moderate swelling, <2.5 cm with redness, crusting or scab formation; or (3) severe 
swelling, >3.0 cm with blanching or redness. 
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Table 7: Mean values and standard deviations (in brackets) of clinical and behavioural parameters at 
different times after SLS treatment of 6 sheep in the main study. 
 
                Time 
 Parameters 
0 min 0.5 hr 4 hr 8 hr 12 hr 1 day 2 day 3 day 4 day 
Rectal temp 
(°C) 
38.47 
(0.10) 
38.52 
(0.12) 
38.72 
(0.22) 
38.77 
(0.27) 
38.88 
(0.31) 
38.92 
(0.12) 
38.68 
(0.21) 
38.70 
(0.24) 
38.67 
(0.17) 
Heart rate (per 
min) 
72.83 
(0.75) 
75.67 
(0.82) 
76.00 
(0.89) 
77.00 
(1.41) 
79.00 
(1.10) 
80.00 
(1.79) 
77.33 
(0.82) 
76.00 
(0.89) 
75.83 
(0.98) 
Respiration 
(per min) 
13.00 
(0.89) 
13.83 
(0.75) 
15.00 
(0.63) 
15.33 
(0.82) 
17.00 
(0.63) 
16.67 
(1.03) 
15.67 
(0.82) 
14.00 
(1.10) 
14.00 
(0.89) 
MM 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
CRT 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
General 
demeanour 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.50 
(0.55) 
0.50 
(0.55) 
0.00 
(0.00) 
0.00 
(0.00) 
Posture & 
movement 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.50 
(0.55) 
0.50 
(0.55) 
0.00 
(0.00) 
0.00 
(0.00) 
Gait & co-
ordination 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
Appetite - - - 0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
0.00 
(0.00) 
 
Scores for clinical and behavioural parameters were taken before and after skin biopsy respectively. 
Behavioural patterns were observed after recovery from sedation, over a 30-minute period. General 
demeanour was scored as (0) bright, alert and responsive, (1) hyperactive/restless, (2) depressed, 
and (3) coma. Movement and posture were scored as (0) normal, (1) biting/rubbing/skin twitching 
of treated sites, (2) arching back, and (3) head drooping. Gait and coordination were scored as (0) 
normal, (1) ataxia, (2) paresis, (3) paralysis. Appetite for food or drink was scored as (0) normal, (1) 
abnormal or (-) not applicable in fasted sheep. Mucous membrane/MM colour was scored as (0) 
pink, (1) pale or (2) otherwise. Capillary refill time/CRT was scored as (0) normal <2 seconds, or 
(1) abnormal >2 seconds. 
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4.2.3. Histological changes at varying times after SLS treatment 
 
The histopathology following SLS treatment was severe and more peracute in the deep layers than 
the superficial layers of the skin. The early necrosis of all soft tissue structures in the subcutis and 
deep dermis after treatment was followed by subsequent additional ischaemic necrosis of the 
superficial dermis and epidermis with progressive inflammation, proliferation and remodelling of 
the wound. 
 
Initial histopathologic changes were observed within the deep layers (subcutis and deep dermis) of 
the skin. At 2 minutes after injection endothelial cells lining the blood vessels were hypertrophic 
(reactive); lymphatic vessels were dilated and the subcutis was expanded by loosely arranged 
interstitium. Vessels, nerves and other soft tissue structures in the deep dermis and subcutis were 
affected by coagulative necrosis which was characterised by hypereosinophilia with loss of cellular 
details and karyolytic remnants (Figure 10). Collagen bundles appeared disrupted and disorganised, 
with loss of birefringence. Tissue necrosis was associated with minimal multifocal clusters of fine 
granular basophilic material, which was histochemically negative for calcium with the use of von 
Kossa stain.
169, 170
 Deep hair bulbs were basophilic with irregularities in the outline of the basement 
membrane (lamina). Inflammatory infiltrates and haemorrhage were initially absent at the site of 
treatment in the deep skin layers. However a pre-existing mild inflammation was noted in the 
superficial dermis which was not a treatment effect. 
 
Deep tissue necrosis was moderate at 10 minutes and persisted until the third day after SLS 
treatment. By day 1 there was moderate and multifocal thrombosis characterised by the occlusion of 
damaged small arteries by hypereosinophilic fibrillar material (interpreted as fibrin thrombi); 
thrombosis however was not noted in the superficial skin layers throughout the trial period. From 
day 1 onwards both skin layers were affected by moderate subcutaneous oedema with moderate to 
severe infiltration of neutrophils adjacent to areas of necrosis. Moderate inflammation of the 
subcutis developed at 6 hours and consisted predominantly of perivascular to interstitial infiltrates 
of 100-200 neutrophils per x40 field (Figure 11).  
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Figure 10: Tissue hypereosinophilia with loss of cellular detail indicating coagulative necrosis; 
interstitial separation (1), lymphatic dilation (2) and distortion of deep hair bulbs (3) at 2 minutes 
after SLS treatment. Sheep skin; haematoxylin and eosin stained section. Bar = 502µm. 
Magnification = 400x. 
 
Epidermal necrosis, oedema and neutrophil infiltration were detected at day 2. Multifocal 
subcorneal clefts which contained moderate numbers of neutrophils were noted adjacent to the 
necrotic epidermis. The epidermis also contained minimal neutrophilic exocytosis and spongiosis 
(intercellular oedema). Necrosis of the superficial dermis and epidermis was not observed until day 
2, in contrast with the early necrosis of the subcutis and deep dermis which occurred within 2 
minutes. Thrombosis, which was a feature of deep cutaneous necrosis was not encountered in the 
necrotic superficial layers of the skin. 
 
 
79 
 
 
 
Figure 11: Acute inflammation of the subcutis and deep dermis developed 6 hours after treatment. 
The tissue architecture was altered by necrosis, moderate neutrophilic infiltration (1) and oedema 
characterised by interstitial separation (2) and lymphatic dilation (3). Sheep skin; haematoxylin and 
eosin stained section. Bar = 498µm. Magnification = 200x. 
 
Active fibroplasia and angiogenesis were evident by day 7 (Figure 12) and was accompanied with 
subsequent tissue granulation within the deep dermis and subcutis. Reepithelialisation was initiated 
at day 7 at the edge before migrating under the thick necrotic scab (eschar) which was bordered by 
minimal to moderate infiltration of polymorphonuclear and mononuclear inflammatory cells. 
Fibroplasia continued through 14, 21 and 28 days after treatment. Granulation tissue developed 
initially within the deep dermis and subcutis and was characterised by proliferation of disorganized 
and parallel fibroblasts of immediate maturity and formation of parallel vessels perpendicular to the 
tissue surface. Angiogenesis and fibroplasias progressed at similar rates and therefore had similar 
scores. There was progressive collagen deposition within the stroma, from short, thin fibres of high 
cellularity and low birefringence to thick, parallel or whorled fibres of low cellularity and high 
birefringence. 
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Figure 12: At 7 days after treatment, there was active fibroplasia and angiogenesis (1) adjacent to 
the necrotic dermis (2). There was early epidermal reepithelialisation (3) adjacent and subjacent to 
the necrotic eschar (4). Sheep skin; haematoxylin and eosin stained section. Bar = 498µm. 
Magnification = 200x. 
 
Reepithelialisation was completed by day 21 over a newly formed dermis consisting of fibrous 
tissue with little or no adnexal units (Figure 13). Necrotic eschar (scab) remained attached to the 
underlying reepithelialised wound bed and was partially sloughed off over the 28-day trial period. 
The newly formed epithelium was mildly to moderately hyperplastic. Extending downwards from 
the superficial dermis into the subcutis the resulting scar formation was characterized 
predominantly by absence of adnexal structures and replacement by dense fibrous tissue which was 
progressively more mature and organized into parallel spindle cells. Sparse numbers of diminutive 
adnexal units were rarely noted in the dermal granulation (scar) tissue. Superficially there was 
chronic-active inflammation, characterised by minimal to moderate infiltrates of lymphocytes, 
plasma cells, neutrophils, macrophages and the infrequent multinucleated Langhans-type giant 
cells. 
 
2 
1 
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Figure 13: Complete reepithelialisation (1) with overlying eschar, and dermal fibrosis (2) at 28 days 
after treatment. Note the rare diminutive adnexal unit (3). Sheep skin; haematoxylin and eosin 
stained section. Bar = 498µm. Magnification = 200x. 
 
Median grading of histopathologic changes in the superficial and deep layers of skin specimens 
over time after SLS treatment is summarized in Table 8 and presented schematically in Figure 14. 
Calculations of the mean and standard deviation of the histopathologic grades within both skin 
layers are presented schematically in Figures 15A and 15B, which show how much variation 
existed from the averaged scores of histopathologic changes in the treated skins from the 6 sheep.  
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Table 8: Median grades of skin histopathologic changes at specific time points after SLS treatment 
of 6 sheep in the main study. 
 
 
 
 
Time 
Median scores of histopathologic changes in the different skin layers 
Superficial (epidermis + superficial dermis) Deep (deep dermis + subcutis) 
I O Fn H N A Fs C Re I O Fn H N A Fs C 
0 min 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 min 1 0 0 0 0 0 0 0 0 0 0.5 0 0 0.5 0 0 0 
5 min 1 0 0 0 0 0 0 0 0 0 1 0 0 1.5 0 0 0.5 
10 min 1 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0.5 
15 min 1 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0.5 
30 min 1 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 1 
1 hr 1 0 0 0 0 0 0 0 0 0 2 0 0 2.5 0 0 1 
2 hr 1 0 0 0 0 0 0 0 0 0 2 0 0 2.5 0 0 1 
4 hr 1 1 0 0 0 0 0 0 0 1 2 0.5 0 2.5 0 0 1 
6 hr 1 1 0 0 0 0 0 0 0 1.5 2 0.5 0 2.5 0 0 1 
1 day 1.5 2 0 0 0 0 0 0 0 2.5 2 2 0 2.5 0 0 1 
2 day 2.5 0.5 0 0 2 0 0 1 0 2 2 1.5 0.5 2.5 0 0 1.5 
3 day 2.5 0 0 0 3 0 0 1 0 1.5 1 0.5 0.5 3 0.5 0.5 2 
7 day 1 0 0 0.5 1 0.5 0.5 1.5 1 1 0 0 0 1 2 2 2 
14 day 1 0 0 0 0 1 1 2 2 1 0 0 0.5 0 2 2 2 
21 day 1 0 0 1 0 2 2 2 3 1 0 0 1 0 2 2 2 
28 day 1 0 0 0.5 0 2 2 2.5 3 2 0 0 1 0 3 3 3 
 
SLS treated skin biopsies are fixed and stained with H & E. The degree of histopathologic changes 
(I = inflammation, O = oedema, Fn = fibrin, H = haemorrhage, N = necrosis, A = angiogenesis, Fs = 
fibrosis, C = collagen, Re = reepithelialisation) within the superficial layers (epidermis, upper hair 
follicles and sebaceous glands) and deep layers (lower hair follicles, apocrine glands and subcutis) 
are graded using a 4-point grading system (0 = no change, 1 = mild change, 2 = moderate change, 3 
= marked change). Medians were calculated from n = 6 individual sheep skin biopsies. 
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Figure 14: Schematic presentation of median scores of microscopic changes in the superficial skin 
(epidermis, upper hair follicles and sebaceous glands) and deep skin (lower hair follicles, apocrine 
glands and subcutis) layers of 6 sheep after treatment with SLS in the main study. Pre-existing mild 
inflammation and absence of fibrin was observed in the superficial skin layer. Similar scores were 
noted for angiogenesis and fibrosis (which led schematically to their merging and the loss of 
angiogenesis) in both skin layers.  
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Figure 15A: Schematic presentation of mean scores and standard deviation of microscopic changes 
(necrosis, inflammation, reepithelialisation and fibrin) in the superficial skin (epidermis, upper hair 
follicles and sebaceous glands) and deep skin (lower hair follicles, apocrine glands and subcutis) 
layers of 6 sheep after treatment with SLS in the main study. Pre-existing mild inflammation and 
absence of fibrin were observed in the superficial skin layers. Figure continues on to the next page. 
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Figure 15B: Schematic presentation of mean scores and standard deviation of microscopic changes 
(angiogenesis, fibrosis and collagen) in the superficial skin (epidermis, upper hair follicles and 
sebaceous glands) and deep skin (lower hair follicles, apocrine glands and subcutis) layers of 6 
sheep after treatment with SLS in the main study. Similar scores were noted for angiogenesis and 
fibrosis in both skin layers. 
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4.2.4. Early ultrastructural changes after SLS treatment 
 
Ultrastructural changes were noted as early as 2 minutes after SLS treatment. These changes were 
mainly observed within the deep dermis and subcutis with the following components specifically 
affected: blood vessels, lymph vessels, hair follicles, and connective tissue (extracellular matrix).  
 
The most severely damaged areas were effaced by loss of architecture, presence of electron-dense 
granular necrotic debris (remnant of putative blood vessels, lymph vessels or hair follicles) and 
separation of fragmented collagen fibres by electron-lucent material (oedema) accumulating within 
the extracellular matrix (Figure 16).  
 
 
 
Figure 16: Severe tissue necrosis characterized by accumulation of electron-dense granular necrotic 
debris including remnant of putative blood vessel or hair follicle with degenerate red blood cells or 
follicle epithelial cells respectively (A). Note the electron-lucent oedema fluid (B) in the 
extracellular matrix. 2 minutes after SLS treatment. Sheep skin, dermis; transmission electron 
microscopy section. Bar = 2µm. Magnification = 15,000x.  
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Blood vessels 
Severely damaged blood vessels (Figure 17) displayed endothelial cell degeneration with an 
irregular basement membrane and separation and fragmentation of the adventitial layers. 
Endothelial cells were enlarged and contained an electron-lucent, rarely vacuolated, cytoplasmic 
matrix, randomly scattered granular material (consisting of remnants of cytoplasmic organelles and 
dispersed ribosomes), with loss of organelles and vesicles. Where visible, nuclei contained 
multifocal aggregates of electron-dense chromatin along the nuclear membrane (chromatin 
margination). The endothelial basement membrane was segmentally disrupted. Loss of pericytes 
and smooth muscle cells was evident with complete disorganisation of the blood vessel wall. The 
extracellular matrix contained fragmented and disorganized collagen fibres. The lumen of the blood 
vessel was filled with necrotic cell debris. Occasionally, degenerated endothelial cells were 
detached from the basement membrane, sloughing into the lumen (Figure 18). Figure 19 illustrates a 
normal blood vessel from an untreated, control skin tissue.  
 
 
Figure 17: Damaged blood vessel: endothelial cell (E) degeneration with electron-lucent 
cytoplasmic matrix and loss of organelles, vesicles and nucleus. There is segmental disruption of 
the endothelial basement membrane (BM) with loss of pericytes and smooth muscle cells. The 
extracellular matrix (ECM) contained fragmented and disorganised collagen fibres. 2 minutes after 
SLS treatment. Sheep skin; transmission electron microscopy section. Bar = 200nm. Magnification 
= 15,000x. 
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Figure 18: Early less damaged blood vessel: detachment of endothelial cells (E) from the basement 
membrane (BM) into the lumen. Degenerated cells contained cytoplasmic vacuoles. The chromatin 
(C) is marginated. Note the preserved pericyte structure (P). 2 minutes after SLS treatment. Sheep 
skin, deep dermis; transmission electron microscopy section. Bar = 2µm. Magnification = 4,000x.   
 
Lymph vessels 
Ultrastructural changes similar to those described for the blood vessels were also observed in the 
lymph vessels. Loss of normal architecture and degeneration of endothelial cells occurred (Figure 
20). Degenerated endothelial cells contained diffuse electron-lucent cytoplasm (cytoplasmic 
rarefaction) with loss of nucleus and organelles. The basement membrane was irregular while 
collagen fibres in the extracellular matrix were disorganized, fragmented, and separated by electron-
lucent spaces (oedema). 
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Figure 19: Normal blood vessel which is lined by endothelial cells (E) containing an electron-dense 
nucleus and an outer pericyte (P) with a moderately electron-dense nucleus. Red blood cells (RBC) 
are noted within the lumen of the blood vessel. Untreated, control sheep skin, deep dermis; 
transmission electron microscopy section. Bar = 2µm. Magnification = 4000x. 
 
 
Figure 20: Lymph vessel with loss of the normal architecture. Note the irregular basement 
membrane (BM), degenerated endothelial cells (E) and disorganised and fragmented collagen fibres 
separated by oedema in the extracellular matrix (ECM). 2 minutes after SLS treatment. Sheep skin, 
deep dermis; transmission electron microscopy section. Bar = 5µm. Magnification = 6,000x. 
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Hair follicles 
After SLS treatment, severe degeneration of the hair follicles was observed, effacing both the 
basement membrane and the follicular epithelium (inner and outer root sheath). Figure 21 illustrates 
a normal hair follicle from a non-affected area at 2 minutes after SLS treatment. Although a mild 
spongiosis could be observed in normal conditions, the architecture of the root sheath epithelium, 
cuticle, basement membrane and fibroblasts in the extracellular matrix was well preserved. In 
comparison, the hair follicles within the affected areas were severely degenerated (Figures 22A, 
22B) with either fragmentation or splitting of the follicular basement membrane. Necrotic follicular 
epithelial cells contained a diffuse electron-lucent cytoplasm, without any discernible organelles 
and nuclear remnants. The extracellular matrix was degenerated with collagen fibre fragmentation 
and oedema. 
 
 
 
Figure 21: Normal, unaffected hair follicle at 2 minutes after SLS treatment. There is mild 
spongiosis (intercellular oedema characterised by small clear vacuoles) in the outer layer of the 
follicular epithelium (FE). The keratin (K), basement membrane (BM), extracellular matrix (ECM) 
and fibroblasts (F) are structurally normal. Sheep skin, deep dermis; transmission electron 
microscopy section. Bar = 10µm. Magnification = 2,500x.
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Figure 22: Severely degenerated hair follicle at 2 minutes after SLS treatment. A) Splitting 
and fragmentation of the follicular basement membrane (BM). No organelles or nuclear 
structure are evident in the necrotic follicular epithelial cell (FE). The extracellular matrix 
(ECM) is degenerated with collagen fibre fragmentation and oedema. Bar = 2,000nm. 
Magnification = 12,000x. B) A higher magnification showing fragmentation of the follicular 
basement membrane (BM), with oedema in the extracellular matrix (ECM). Sheep skin, deep 
dermis; transmission electron microscopy section. Bar = 500nm. Magnification = 40,000x. 
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4.3. Discussion 
 
 
4.3.1. Gross and microscopic pathology 
 
The main study trialled the administration of SLS via a needleless applicator, SkinTraction® and 
assessed the effectiveness of the chemical at producing a painless, hairless scar formation which has 
the potential to stretch and modify the breech for reduced susceptibility to blowfly strike. 
 
The initial soft tissue swelling of approximately 1 cm in diameter after treatment correlated to the 
diffusion of SLS solution over 0.5 cm in each direction following a pressurised needleless injection. 
The severity and time course of gross changes noted in this study concur with a previous study
102
 
which reported an overall minimal gross tissue reaction of swelling and scab formation from intra-
dermal SLS in comparison to the more severe responses to intra-dermal injection of cetrimide in 
other studies
104
 which produced severe bruising,
109
 and marked initial swelling before subsequent 
formation of hard scabs with observed substantial purulent exudate beneath lifted scabs.
108
 The 
relatively mild gross pathology associated with intra-dermal SLS increases its attractiveness as a 
chemical alternative to surgical mulesing in sheep.   
 
SLS treatment of sheep skin caused rapid, widespread and non-specific necrosis of dermal and 
subcutaneous tissue structures including adnexal units, vasculature, nerves and collagen bundles. 
Although sensory nerve endings which terminate in the superficial skin layers could not be assessed 
by H & E and special stains
133
 due to their low distribution and fine structure, they were presumably 
destroyed in a similar manner to the sensory nerve fibres of the cutaneous nerve plexus in the deep 
dermis during the early necrotic process. Necrosis of deep cutaneous nerve plexus was observed on 
histology in the sighting study (see Figure 7B). The prompt destruction of sensory nerves 
responsible for pain sensation followed by healing with scar tissue replacing adnexal units further 
promotes SLS as an effective chemical alternative to mulesing. Sparsely distributed diminutive 
remnant hair follicles were unlikely to affect the overall wound contraction provided by the 
abundant granulation (scar) tissue. However, the potential of some fibre regrowth after treatment 
remains a possibility although this is unlikely to detract from the overall effectiveness. 
Nevertheless, the end result of minimal fibre regrowth when applied to the breech requires 
validation by extended evaluation weeks or months after the treated area has completely healed. 
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The use of the SkinTraction® applicator for pressurized automated needleless delivery of SLS 
effectively targeted the deep dermis which contained adnexal units and nerve plexus, thus 
destroying the vital structures to produce a painless depilated scar tissue with comparable efficiency 
to mulesing. The needleless applicator was relatively simple to use and by ensuring the delivery 
tubes were evenly loaded against the skin, provided uniform intra-dermal deposition of SLS. Its 
application in the field would require training of operators but the procedure has advantages in 
terms of portability with automated delivery to ensure dose accuracy and minimise user fatigue or 
human error,
105, 107
 while being less stressful and more welfare friendly than surgical mulesing in 
restrained sheep with clipped and antiseptically prepared breeches.  
 
The onset of early necrosis of deep dermis and subcutis at 2 minutes after SLS treatment was 
similar in both the sighting and main studies. However, the extent of deep tissue necrosis in the 
main study was less (with a median grading of 2.5) than that of the sighting study (with a median 
grading of 3). Deep tissues which were less severely affected by necrosis in the main study allowed 
histological grading and comparison of skin samples, in contrast to the problem of extensive 
necrosis precluding histological grading of parameters (inflammation, oedema, haemorrhage and 
fibrosis) in the sighting study. This could infer a lower and more evenly concentrated SLS effect 
provided by the SkinTraction® applicator which prevented widespread cell membrane lysis and 
tissue necrosis while preserving viable cells for histologic assessment and grading. 
 
The time for wound healing with complete reepithelialisation after intra-dermal SLS treatment took 
approximately 21 days which was similar to the sighting study. The process of wound healing with 
complete reepithelialisation took significantly longer than the complete reepithelialisation of 5-7 
days which occurred in a study by McMullen (1995) following uncomplicated healing of 6-mm 
punch biopsy of sheep skin.
179
 The delay in reepithelialisation, wound healing and subsequent 
sloughing in the main and sighting studies was hypothesized to have resulted from the deep 
subcutaneous necrosis which takes longer to resolve, slowing wound healing, epithelial 
regeneration and sloughing of eschar. Although the use of the intra-dermal SkinTraction® 
applicator reduced the extent of necrosis, it did not translate to a clear reduction in healing time. It is 
possible to promote wound healing by reducing the extent of skin necrosis via decreasing the dose 
of SLS administered. Further trials are required to optimise SLS dose and applicator variables by 
refining settings such as volume per administration, volume per tube, number of tubes per nozzle 
head and pressure of tubes against the skin surface.
201
 In addition, the use of larger sample sizes in 
the treatment and control groups would be necessary to detect any subtle differences of real 
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significance with respect to the extent of pathology and progress of wound healing in SLS-treated 
skin. 
 
Calculations of the mean and standard deviation of the histopathologic grades within both skin 
layers showed relatively large variations in the range of values (high standard deviations) from 
several of the averaged scores of histopathologic changes in the treated skins of the 6 sheep. This 
inferred the influence of factors which led to variation in scoring, in terms of missed sampling of 
treated tissue and sampling instead from less affected tissue adjacent to area of histopathology. 
Therefore the increased care with handling and punch biopsy procedures did not appear to improve 
the problem of missed sampling which was similarly encountered in the sighting study.  
 
The variation in scoring could be influenced by differences in individual sheep reaction to the 
treatment with a possibility of variation in the dispersion of SLS within tissues. In this regard, dye 
studies would be useful to investigate chemical dispersion after deposition and its effect on the 
dosage in situ. Other variable factors include inconsistencies in drug concentration caused by 
precipitation; SLS concentration of 0.1% or greater has been shown to result in non-specific 
precipitation with serum proteins and lipoproteins in agar diffusion and immunoeletrophoresis.
178
 
The latter could explain the appearance of basophilic deep hair bulbs with irregular basement 
membrane and small multifocal clusters of fine granular material within the necrotic tissues. 
Presumably, the needleless intra-dermal applicator designed for accurate delivery of drug dose
105, 107
  
and its application on the flat and small-sized  treatment areas of the flank skin would be unlikely to 
cause the large variations in range of values from the mean grades of histopathologic changes 
observed. In order to confirm or rule out the possible factors causing discrepancies in 
histopathologic scoring, further trials using a larger sample size and/or multiple pathologists for 
scoring skin sections would be required. 
 
 
4.3.2. Ultrastructural Pathology 
 
The early ultrastructural changes of capillary endothelium in the subcutis and deep dermis after SLS 
treatment reflected severe endothelial degeneration rather than activation associated with peracute 
inflammation. The acute necrosis and degeneration of the endothelium of both lymph and blood 
vessels along with the deep dermal epithelial structures (hair follicles and associated glands) were 
caused by direct damage to the cellular membranes of the cytoplasmic organelles and basal lamina 
respectively. The early yet extensive necrosis of vascular endothelium in conjunction with other 
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tissue structures in the subcutis and deep dermis indicated involvement of all soft tissue components 
simultaneously following treatment. 
 
 
4.3.3. Postulated mode of action of SLS 
 
SLS treatment produced initial histological and ultrastructural lesions of deep cutaneous necrosis 
which involved all soft tissue structures (vessels, follicles, nerves and collagenous parenchyma). 
This was achieved with an intra-dermal administration of 7% SLS at a calculated dose of 14mg/cm
2
 
for each treatment area.  The demonstrated ultrastructural damage to vascular endothelium and 
follicular basal lamina supports SLS’s mode of action of non-specific binding to proteins of cellular 
membranes with high affinity, resulting in protein unfolding, denaturation and inactivation.
7, 8
 The 
loss in structural integrity of damaged membranes which occurred as early as 2 minutes after 
treatment resulted in immediate necrosis and oedema of the treated subcutaneous tissue. The 
damage to blood vessels compromised vascular supply causing slightly delayed additional ischemic 
necrosis of the overlying dermis and epidermis at days 1 to 2 as noted histologically. 
 
Ultrastructural evidence of early nervous tissue destruction after SLS treatment was not found due 
to the low density of cutaneous nerves in the flank resulting in minimal or no nerve fibres being 
present for assessment on semithin and ultrathin sections. However similar mechanisms of cellular 
membrane degeneration caused by protein unfolding and inactivation presumably also affect 
nervous tissue. Based on histopathology and inference from ultrastructural pathology of vascular 
endothelium and follicular basal lamina, degeneration of sensory nerves would have resulted in 
minimal pain response as early as 2 minutes after treatment with SLS. The extensive subcutaneous 
tissue destruction at 2 minutes suggests an almost instantaneous pathology even prior to this time 
point. 
 
It is postulated that SLS ruptures epidermal intercellular junctions which can predispose to necrosis, 
ulceration and inflammation of the epidermis.
123
 Studies in rats and humans described epidermal 
necrosis and dermatitis from exposure to topical SLS, whereby important ultrastructural findings 
included severe necrosis of the basal layer of the epidermis with loss of the dermo-epidermal 
junction, and marked infiltration of neutrophils.
113, 114
 Given the affect of severe epidermal necrosis 
from studies using topical SLS, we have demonstrated a similar effect on dermal epithelial 
structures in association with intra-dermal treatment; the subsequent cell membrane destruction of 
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follicular epithelial cells (of hair follicles) and nerves would make SLS a potential candidate for a 
less painful chemical alternative to mulesing.  
 
 
4.3.4. General sheep observations 
 
Half of the treated sheep showed signs of restlessness (increased pacing and getting up and down) 
and biting and/or twitching of flank skin on days 1 and 2, which could indicate transient discomfort 
associated with the treatment. These findings were similar to those reported in a previous study 
where the percentage of time spent in abnormal behaviour (increased periods of standing and less 
time lying) by SLS-treated sheep was intermediate between that of the mulesed and control groups 
on days 1 and 2;
102
 although the authors treated the breech and did not address parameters of 
restlessness and biting and/or twitching of skin and therefore precluded any direct comparison with 
the results of our study. 
 
Treated sheep in the current study showed no change in their feeding or interest in food or water 
when compared with untreated sheep. These findings concur with those of a similar study by 
Colditz et al (2010).
102
 In contrast SLS-treated sheep in a study by Hemsworth et al (2009) were 
shown to feed less on day 2 but otherwise no observable behavioural change when compared to the 
control group.
95
 There is some variation in SLS dose and treatment area between the studies 
however, which is likely to at least partially account for the different findings. Although this study 
showed a minimal difference in body weight gain between the control and treatment groups, further 
trials using larger sample sizes would be required to determine if a significant trend exists. 
 
Studies which investigated the effects of different methods to control blowfly reported increases in 
plasma cortisol, haptoglobin and neutrophil to lymphocyte ratio in SLS-treated sheep; these 
responses however were generally less severe and of shorter duration when compared with 
responses from the mulesed animals.
95, 102
 The acute phase protein, haptoglobin is released during 
the acute phase response as part of a systemic reaction, and therefore indicates acute inflammation 
which is typically associated with pain.
190-193
 Haptoglobin was shown to increase significantly and 
for up to 7 days post mulesing in contrast to SLS-treated groups with peak haptoglobin 
concentrations at days 2-3 which returned to baseline on day 7.
95, 102
 Further trials involving 
different techniques of measuring pain would be required to confirm the physiological, behavioural 
and production indicators of pain or discomfort associated with SLS treatment of the breech area. 
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Mulesed sheep were described to deteriorate in gait with decreased live-weight in comparison to the 
control, clip and SLS-treated sheep.
95
 In several studies, mulesed sheep displayed greater levels of 
abnormal behaviours (hunched-up posture and increased periods of standing) for longer periods of 
up to the third day in comparison to the control groups,
74, 75
 even after receiving post-surgical 
analgesia.
102
 Mulesing in general was shown to be less welfare friendly than intra-dermal and clip 
treatment methods to control blowflies in sheep. Regardless of which type of treatment method to 
control blowflies was studied, findings have validated the importance of cumulative welfare 
assessment based on changes in behavioural, physiological and production parameters to detect 
discomfort or stress in animals. 
 
 
4.3.5. Limitations of experimental protocols in the main study 
 
The inclusion of negative controls in the form of skin injected with equal volume of phosphate 
buffered saline (PBS) instead of SLS would have been ideal to differentiate any changes that were 
solely the result of manual injection of a liquid into the dermis. PBS is a common biological buffer 
because it is isotonic (with similar osmolarity to the body) and non-toxic to cells.
202
 Intra-dermal 
injections of PBS alone have been used as controls in studies
203, 204
 with reported histology of 
moderate dermal oedema and blood vessel dilation without inflammation in human skin.
205
 
Similarly previous experiments involving human skin demonstrated redness and swelling at 10 and 
30 minutes associated with needle trauma, followed by mild or no inflammatory reaction 48 hours 
after intra-dermal saline injections.
206
 A vaccine study in pigs demonstrated similar presence of 
small, mild gross and histological lesions at injection sites with no significant difference between 
hypodermic needles and needle-less injections.
107
 Given that these reported changes were transient 
and mild, the severe necrosis seen in tissues in the current study can be safely attributed to the 
trialled intra-dermal SLS treatment rather than the injection process itself. 
 
The ultrastructural analysis was limited to the initial, early stage skin lesions in the subcutis and 
deep dermis, involving connective tissue, lymph and blood vessels, and basement membrane 
structures. It would be equally useful to determine a similar fate in deep cutaneous nerves. If it 
could be confirmed by transmission electron microscopy the mode of complete nervous destruction 
soon after administration of SLS as appears to be the case histologically, this would provide further 
information on how nerves are damaged while supporting the less painful procedure. Ultrastructural 
investigation of possible SLS precipitation with protein molecules, which are either present in the 
extracellular fluid microenvironment or part of the connective tissue ground substance of the 
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extracellular matrix, would provide further understanding on its distribution pattern deep within the 
skin tissue. 
 
Ideally the assessment of pain in sheep would have incorporated measurement of more objective 
parameters such as plasma acute phase proteins (haptoglobin, serum amyloid A and fibrinogen)
190-
193
 and cortisol.
194, 195
 Behavioural assessment of pain was achieved through limited periods of 
observation in this study; however for greater representation of behavioural changes indicating pain, 
other studies observed treated animals for longer periods of time either manually
165
 or by video 
cameras.
95, 102
 Observations for both behavioural and physiological changes in affected animals 
would increase the sensitivity and specificity of pain assessment
189
 of the SLS treated sheep in our 
study. 
 
Buprenorphine, a narcotic analgesia was used in this study for the purpose of animal ethics 
considerations. However Buprenorphine can provide pre-emptive analgesia for up to 12 hours
186
 
and therefore it is likely that any pain associated with intra-dermal SLS treatment would have been 
masked to a degree and the results therefore are not directly comparable to the behavioural 
indicators of acute pain from other studies involving SLS treatment or mulesing. Extensive 
additional studies involving field trials on the breech would have to be done before we can claim 
that there is minimal pain associated with SLS treatment. 
 
The application of an antibacterial fly repellent after the gross assessment and biopsy sampling of 
each SLS-treated skin site did not impact on the analysis of wound healing associated with SLS 
treatment but was rather used to promote the healing of biopsy wound. However, the administration 
of a long-acting preventative antibiotic on day 4 was beneficial in terms of its positive impact on 
wound healing after SLS application by minimizing complications associated with delayed 
reepithelialisation and healing.
64
 While this allowed optimal conditions for assessment of the wound 
healing process following SLS treatment, it would not be practical in field situations. Results from 
this study were therefore not directly comparable to field studies involving SLS treatment or 
mulesing. Further trials using the SkinTraction® applicator for intra-dermal administration of SLS 
into the breech would be required before we can make any meaningful comparison with mulesing in 
the field. 
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5. General discussion 
 
 
5.1. Summary 
 
This study set out to test the hypothesis that intra-dermal SLS is potentially an effective chemical 
alternative to mulesing by initially investigating the effects of SLS treatment on sheep flank through 
the following broad aims: 1) skin pathology with associated healing, 2) mode of action, and 3) 
assessment of pain.  
 
The process of wound healing with complete reepithelialisation took approximately 21 days after 
intra-dermal SLS treatment. Grossly, the initial swelling of the treatment site subsided by day 14 
leaving a firm, slightly raised, crust which became a depressed scab (eschar) at day 21 and partially 
sloughed off by day 28. Histologically, extensive necrosis of structural elements (vessels, follicles, 
nerves and collagen) within the subcutis and deep dermis of the targeted treatment site occurred 
within 2 minutes. Vascular compromise from damaged vessels resulted in slightly delayed 
additional ischaemic necrosis of the superficial dermis and epidermis. Tissue proliferation was 
accompanied by initiation of reepithelialisation at day 7 subjacent to necrotic scab which 
subsequently sloughed. The underlying fibrosed tissue lacked adnexal units (hair follicles and their 
associated glands). Ultrastructural study confirmed an early and spontaneous damage directly on 
cellular membranes of vascular endothelium and follicular basal lamina. Treated sheep showed no 
abnormalities in appetite and weight gain, with minimal behavioural alterations to implicate 
involvement of severe pain or discomfort. 
 
The fundamental loss of structural integrity of cellular membranes of tissue components is 
consistent with a mode of action of SLS which involves binding strongly with proteins, causing 
their unfolding and inactivation. Intra-dermal SLS caused necrosis, eschar formation and eventual 
scarring of treated skin as demonstrated on histopathology which manifested grossly as a bare, 
hairless area of contracted tissue. This study addressed its aims by demonstrating the rapid and 
effective destruction of hair follicles and sensory nerves with minimal discomfort in treated sheep. 
We can therefore speculate that intra-dermal SLS has potential as a suitable candidate for a less 
painful chemical alternative to mulesing. Its application to the breech could possibly result in scar 
formation and skin contraction to increase the bare area, thus minimising faecal and urine 
contamination of wool which predisposes to flystrike. 
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5.2. Avenues for further research 
 
The sensitivity of pain assessment is generally improved by combining behavioural, physiological 
and production parameters. Accurate objective measurements of physiological pain are obtained  
from plasma markers of inflammation such as acute phase proteins which are released during the 
acute phase response as part of a systemic reaction,
190-193
 and cortisol hormone which is released by 
the hypothalamic-pituitary-adrenocortical system in response to tissue damage.
194, 195
 Other patented 
systems available for objective pain measurements 
207, 208
 allow quantification of electrical activity 
of stimulated neural receptors via the use of electrodes. Quantifying the response of stimulated 
receptors of the peripheral nervous system would also provide objective measurements of different 
types of pain. Serial measurements immediately after treatment and at subsequent time intervals 
would improve the accuracy of detecting a pain response. Muted pain responses from spray-on 
anaesthtic following husbandry procedures have been measured directly through assessment of 
wound sensitivity in combination with behavioural, observations, digital photography, computer-
assisted wound surface mapping
80, 81
 and wound thermography.
78
 Regardless of which approach is 
used to measure pain, the best outcome would be achieved by measures of multiple parameters from 
objective and subjective assessments of pain,
167
 which are valid and reliable in practical settings.
187
 
 
The current study provides an initial indication of SLS having a potential as an effective alternative 
to surgical mulesing and intra-dermal administration does not produce strong adverse effects on 
sheep. One of the next steps in research is to investigate whether similar effects of SLS induced 
depilation and contraction could be achieved in the breech. This would involve optimising the dose 
of SLS treatment of the breech to achieve the desired effect of breech modification; further trials 
using larger sample sizes in the treatment, control and mulesed groups would enable comparative 
assessments of the welfare outcomes using behavioural, physiological and production indicators of 
pain after the treatment procedures. The effectiveness of breech modification in reducing flystrike 
susceptibility could be evaluated from trial periods which extend beyond wound healing to 
investigate the influence of potential fibre regrowth in SLS-treated skin. The dimension of perineal 
breech area would ideally be recorded before and after treatment to allow evaluation in the 
effectiveness of the resulting scar formation in tightening the skin and increasing the bare area of 
the breech. 
 
This study focused on qualitative rather than quantitative research, in which we were not trying to 
quantify the percent efficacy of the SLS treatment but focus instead on understanding the 
pathological effects of the intra-dermal treatment by intensive study of a few animals. 
101 
 
Hypothetically the optimal sample size for a quantitative study would require defining the 
measurement of how “effective” the treatment is on the breech for x% of animals and would 
involve comparison with a control group.
209
 Previous quantitative studies comparing intra-dermal 
treatment with mulesing of the breech have used 11 to 30 sheep per treatment and control group, 
and these produced results of statistically significant difference.
63, 95, 102
 
 
The statistics package called R
210
 could be used to calculate the statistical power of optimal sample 
size by simulation (as there are no analytical formulae for this case) for a given scenario of 
proportions. By scoring a response as one of 4 categories, "none", "mild", "moderate", "severe" in 
treated and control animals and using the Mann-Whitney U test for the calculation (a non-
parametric version of the t-test, since the response is categorical/ordinal, rather than being measured 
on a continuous scale) we can present the following scenario:
209
 
1) In control animals, that 90% will be "none" (no symptoms), 9% have mild symptoms, and 
1% has moderate symptoms (and 90+9+1=100%) 
2) In treated animals, only 20% will be "none" (no symptoms), 75% are mild, 4% are moderate 
and 1% is severe (20+75+4+1=100%) 
If we have 6 treated animals and 3 control (as in our case), we would have around 45% power 
(chance of detecting a difference between treated and control). If we had 12 treated and 6 control 
animals, we would have around 84% power which would be acceptable in most cases in producing 
statistically significant difference that is meaningful and reliable enough to inform further decision 
making. Ideally with 24 treated and 12 control animals, we would have around 99% power or 
chance of getting a statistically significant difference.  
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5.3. Future implications 
 
Needleless intra-dermal SLS application to the breech if successful could be trialled on a large 
scale. Promising results would allow the chemical product to be used commercially. Ultimately this 
would ensure the maintenance and improvement of sheep health and welfare by providing an 
alternative to mulesing. The Mules procedure itself is viewed by animal rights activists as an act of 
cruelty and plans are in place to phase out mulesing in the future by the wool industry. Replacement 
of surgical mulesing with a safer and less painful alternative such as the needleless, intra-dermal 
SLS treatment would optimise welfare values and help sustain the economy of wool production. 
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Statistical power calculated by simulation for a given scenario of proportions using sample sizes of 
6 treated and 3 control animals gives 45 % chance of detecting a significant difference. 
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Statistical power calculated by simulation for a given scenario of proportions using sample sizes of 
12 treated and 6 control animals gives 84 % chance of detecting a significant difference. 
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Statistical power calculated by simulation for a given scenario of proportions using sample sizes of 
24 treated and 12 control animals gives 99 % chance of detecting a significant difference. 
 
 
 
 
